[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_ffc0556e-c3b5-4d88-9a74-feb5b6266bfd":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:ffc0556e-c3b5-4d88-9a74-feb5b6266bfd,\"}":40},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":21,"indexDatabases":22,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"ffc0556e-c3b5-4d88-9a74-feb5b6266bfd","2023-11-26T09:29:55.746+00:00","2025-11-21T09:57:35.501+00:00",[],"Seminars-in-Neuroscience",{"issn":12,"title":14},{"VOID":13},"10445765",{"EN":15},"Seminars in Neuroscience","PUBLISHER","PENDING",null,0,[],[],[23],{"id":24,"indexDatabase":25,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},"60ab476a-d3f8-4bf0-bd6e-a753919d4230",{"id":26,"createTime":27,"updateTime":28,"relativeEntities":29,"label":30,"description":32,"key":34,"publicationTags":35,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":31,"VI":31},"Scopus - Elsevier",{"EN":31,"VI":33},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[36],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F19387","1991-1998","SCOPUS__Q3",{"meta":41,"data":43},{"total":42},"138",[44,116,166,242,292,337,405,469,518,604],{"id":45,"createTime":46,"updateTime":47,"relativeEntities":48,"slug":49,"properties":50,"entityType":57,"verifyStatus":58,"verifyTime":47,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":60,"fullTextUrl":18,"authors":61,"publicationType":92,"publisherRelationship":93,"citationCount":18,"citationInfo":18,"publishDate":113,"publishYear":114,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"360b18a1-ea49-4b18-ab12-e05a671789ff","2024-02-10T12:27:16.988+00:00","2025-02-09T23:56:55.165+00:00",[],"Androgen-receptor-expression-and-sexual-differentiation-of-effectors-for-courtship-song-in-Xenopus-laevis",{"references":51,"title":53,"doi":55},{"VOID":52},"Kelley, 1988, Sexually dimorphic behavior, Annu Rev Neurosci, 11, 225, 10.1146\u002Fannurev.ne.11.030188.001301\nArnold, 1985, Organizational and activational effects of sex steroids on brain and behavior: a reanalysis, Horm Behav, 19, 469, 10.1016\u002F0018-506X(85)90042-X\nEvans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126\u002Fscience.3283939\nWetzel, 1983, Androgen and gonadotropin control of the mate calls of male South African clawed frogs, Xenopus laevis, Horm Behav, 17, 388, 10.1016\u002F0018-506X(83)90048-X\nTobias, 1987, Vocalizations by a sexually dimorphic isolated larynx: peripheral constraints on behavioral expression, J Neurosci, 7, 3191, 10.1523\u002FJNEUROSCI.07-10-03191.1987\nSassoon, 1986, Androgen-induced myogenesis and chondrogenesis in the larynx of Xenopus laevis, Dev Biol, 113, 135, 10.1016\u002F0012-1606(86)90115-6\nFischer, 1990, Sex specific androgen receptor mRNA expression during laryngeal development in Xenopus laevis, J Cell Biol, 11, 284\nHannigan, 1986, Androgen-induced alterations in vocalizations of female Xenopus laevis: modifiability and constraints, J Comp Physiol A, 158, 517, 10.1007\u002FBF00603797\nKelley, 1980, Auditory and vocal nuclei of frog brain concentrate sex hormones, Science, 207, 553, 10.1126\u002Fscience.7352269\nKelley, 1989, Development and hormone regulation of androgen receptor levels in the sexually dimorphic larynx of Xenopus laevis, Dev Biol, 131, 111, 10.1016\u002FS0012-1606(89)80042-9\nSassoon, 1986, The sexually dimorphic larynx of Xenopus laevis: development and androgen regulation, Am J Anat, 177, 457, 10.1002\u002Faja.1001770404\nLuine, 1980, Androgen affects cholinergic enzymes in syringeal motor neurons and muscle, Brain Res, 192, 89, 10.1016\u002F0006-8993(80)91011-2\nBreedlove, 1983, Hormonal control of a developing neuromuscular system: I. Complete demasculinization of the spinal nucleus of the bulbocavernosus in male rats using the anti-androgen, flutamide, J Neurosci, 3, 417, 10.1523\u002FJNEUROSCI.03-02-00417.1983\nForger, 1991, Steroid influences on a mammalian neuromuscular system, Semin Neurosci, 3, 459, 10.1016\u002F1044-5765(91)90055-S\nWetzel, 1985, A proposed efferent pathway for mate calling in South African clawed frogs, Xenopus laevis: tracing afferents to laryngeal motor neurons with HRP-WGA, J Comp Physiol A, 157, 749, 10.1007\u002FBF01350072\nSchmidt, 1984, Neural correlates of frog calling: preoptic area trigger of “mating calling”, J Comp Physiol, 154, 847, 10.1007\u002FBF00610685\nKelley, 1988, Sex differences in the motor nucleus of cranial nerve IX–X in Xenopus laevis: a quantitative Golgi study, J Neurobiol, 19, 413, 10.1002\u002Fneu.480190503\nKelley, 1990, The vocal motor neurons of Xenopus laevis: development of sex differences in axon number, J Neurobiol, 21, 869, 10.1002\u002Fneu.480210605\nNieuwkoop, 1956\nYaeger, 1982, A novel mechanism for underwater sound production in Xenopus borealis, Am Zool, 122, 887\nRidewood, 1898, On the structure and development of the hyobranchial skeleton and larynx in Xenopus and Pipa; with remarks on the affinities of the aglossa, Linn Soc J Zool, 26, 53, 10.1111\u002Fj.1096-3642.1897.tb00243.x\nMarin, 1990, Hormone sensitive stages in the sexual differentiation of laryngeal muscle fiber number in Xenopus laevis, Development, 110, 703, 10.1242\u002Fdev.110.3.703\nSassoon, 1987, Androgen regulation of muscle fiber type in the sexually dimorphic larynx of Xenopus laevis, J Neurosci, 7, 3198, 10.1523\u002FJNEUROSCI.07-10-03198.1987\nTobias, 1991, Development of functional sex differences in the larynx of Xenopus laevis, Dev Biol, 147, 251, 10.1016\u002FS0012-1606(05)80022-3\nTobias, 1991, Temporal constraints on androgen directed laryngeal masculinization in Xenopus laevis, Dev Biol, 147, 260, 10.1016\u002FS0012-1606(05)80023-5\nBottjer, 1991, Neural and hormonal substrates for song learning in zebra finches, Semin Neurosci, 3, 481, 10.1016\u002F1044-5765(91)90057-U\nKelley, 1981, Locations of androgen-concentrating cells in the brain of Xenopus laevis: Autoradiography with 3H-dihydrotestosterone, J Comp Neurol, 199, 221, 10.1002\u002Fcne.901990206\nGorlick, 1986, The ontogeny of androgen receptors in the CNS of Xenopus laevis, Dev Brain Res, 26, 193, 10.1016\u002F0165-3806(86)90283-X\nSegil, 1987, Androgen-binding levels in a sexually dimorphic muscle of Xenopus laevis, Gen Comp Endocrinol, 66, 95, 10.1016\u002F0016-6480(87)90354-6\nWilson, 1981, The hormonal control of sexual development, Science, 211, 1278, 10.1126\u002Fscience.7010602\nYamamoto, 1985, Steroid receptor regulated transcription of specific genes and gene networks, Annu Rev Genet, 19, 209, 10.1146\u002Fannurev.ge.19.120185.001233\nChang, 1988, Molecular cloning of human and rat complementary DNA encoding androgen receptors, Science, 240, 324, 10.1126\u002Fscience.3353726\nLubahn, 1988, Cloning of human receptor complementary DNA and localization to the X chromosome, Science, 240, 327, 10.1126\u002Fscience.3353727\nHe, 1990, Molecular cloning of androgen receptor from divergent species with the PCR technique: complete cDNA sequence of the mouse androgen receptor and isolation of cDNA probes from dog, guinea pig and frog, Biochem Biophys Res Commun, 171, 697, 10.1016\u002F0006-291X(90)91202-4\nLubahn, 1988, The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate, Mol Endocrinol, 2, 1265, 10.1210\u002Fmend-2-12-1265\nKrotowski, 1985, Developmental mutants isolated from wild-caught Xenopus laevis by gynogenesis and inbreeding, J Exp Zool, 233, 443, 10.1002\u002Fjez.1402330313\nFaber, 1991, Characterization of the human androgen receptor transcription unit, J Biol Chem, 266, 10743, 10.1016\u002FS0021-9258(18)99080-0\nQuarmby, 1990, Autologous down-regulation of androgen receptor messenger ribonucleic acid, Mol Endocrinol, 4, 22, 10.1210\u002Fmend-4-1-22\nFischer, 1991, Androgen positive and negative regulation of sexually differentiated gene expression in the larynx of Xenopus laevis, Cell Biochem suppl, 15, 242",{"EN":54},"Androgen receptor expression and sexual differentiation of effectors for courtship song in Xenopus laevis",{"VOID":56},"10.1016\u002F1044-5765(91)90056-t","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F104457659190056T",[62,80],{"id":63,"sortIndex":64,"researcher":18,"roles":65,"affiliations":67,"properties":77},"896b5c96-10bd-4057-ac49-764982d29587",1,[66],"AUTHOR",[68],{"id":18,"sortIndex":19,"affiliation":69,"properties":18},{"id":70,"createTime":71,"updateTime":71,"relativeEntities":72,"slug":18,"properties":73,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"4f39d825-9e43-4a4f-890c-392043a2aa1f","2024-02-10T12:27:17.007+00:00",[],{"title":74},{"VI":75},"From the Department of Biological Sciences, 903 Sherman Fairchild Building, Columbia University, New York, NY 10027, USA","AFFILIATION",{"title":78},{"VI":79},"D.B. Kelley",{"id":81,"sortIndex":19,"researcher":18,"roles":82,"affiliations":83,"properties":89},"b8f04f9a-539c-4e27-9f60-65066763c0e9",[66],[84],{"id":18,"sortIndex":19,"affiliation":85,"properties":18},{"id":70,"createTime":71,"updateTime":71,"relativeEntities":86,"slug":18,"properties":87,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":88},{"VI":75},{"title":90},{"VI":91},"L.M. Fischer","ARTICLE",{"url":60,"publisher":94,"properties":108},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":95,"slug":10,"properties":96,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":99,"manageAffiliations":100,"indexDatabases":101,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":97,"title":98},{"VOID":13},{"EN":15},[],[],[102],{"id":24,"indexDatabase":103,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":104,"label":105,"description":106,"key":34,"publicationTags":107,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":109,"pages":111},{"VOID":110},"3",{"VOID":112},"469-480","1991-12-01",1991,false,{"id":117,"createTime":118,"updateTime":119,"relativeEntities":120,"slug":121,"properties":122,"entityType":57,"verifyStatus":58,"verifyTime":119,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":129,"fullTextUrl":18,"authors":130,"publicationType":92,"publisherRelationship":146,"citationCount":18,"citationInfo":18,"publishDate":165,"publishYear":114,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"bfcc682f-d8ea-4dd2-a0e3-faba2e1c33a5","2023-12-11T05:16:29.234+00:00","2025-01-23T23:49:19.337+00:00",[],"Cadherin-cell-adhesion-molecules-in-vertebrate-neural-development",{"references":123,"title":125,"doi":127},{"VOID":124},"Liesi, 1991, Laminin and fibronectin and their cellular receptors during neural development, Semin Neurosci, 3, 331, 10.1016\u002F1044-5765(91)90050-X\nWalsh, 1991, Structure and function of the gene for neural cell adhesion molecule, Semin Neurosci, 3, 271, 10.1016\u002F1044-5765(91)90045-P\nBieber, 1991, Cell adhesion molecules in the development of the Drosophila nervous system, Semin Neurosci, 3, 309, 10.1016\u002F1044-5765(91)90048-S\nRathjen, 1991, Glycoproteins that regulate the growth and guidance of vertebrate axons: domains and dynamics of the immunoglobulin\u002Ffibronectin type III subfamily, Semin Neurosci, 3, 297, 10.1016\u002F1044-5765(91)90047-R\nTakeichi, 1988, The cadherins: cell-cell adhesion molecules controlling animal morphogenesis, Development, 102, 639, 10.1242\u002Fdev.102.4.639\nTakeichi, 1991, Cadherin cell adhesion receptors as a morphogenetic regulator, Science, 251, 1451, 10.1126\u002Fscience.2006419\nHeimark, 1990, Identification of a Ca2+-dependent cell-cell adhesion molecule in endothelial cells, J Cell Biol, 110, 1745, 10.1083\u002Fjcb.110.5.1745\nHatta, 1986, Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development, Nature, 320, 447, 10.1038\u002F320447a0\nGrunwald, 1982, Enzymatic dissection of embryonic cell adhesive mechanisms. III immunological identification of a component of the calcium-dependent adhesive system of embryonic chick neural retina cells, J Cell Sci, 55, 69, 10.1242\u002Fjcs.55.1.69\nVolk, 1986, A-CAM: a 135 kDa receptor of intercellular adherens junctions I. Immunoelectron microscopic localization and biochemical studies, J Cell Biol, 103, 1441, 10.1083\u002Fjcb.103.4.1441\nTakeichi, 1990, Cadherin subclasses: differential expression and their role in neural morphogenesis, 55, 319\nNagafuchi, 1987, Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA, Nature, 329, 341, 10.1038\u002F329341a0\nRingwald, 1987, The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion, EMBO J, 6, 3647, 10.1002\u002Fj.1460-2075.1987.tb02697.x\nGallin, 1987, Sequence analysis of a cDNA clone encoding the liver cell adhesion molecule, L-CAM, 84, 2808\nNose, 1987, Isolation of placental cadherin cDNA: identification of a novel gene family of cell-cell adhesion molecules, EMBO J, 6, 3655, 10.1002\u002Fj.1460-2075.1987.tb02698.x\nHatta, 1988, Cloning and expression of cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in the cadherin gene family, J Cell Biol, 106, 873, 10.1083\u002Fjcb.106.3.873\nGeiger, 1990, Broad spectrum pan-cadherin antibodies, reactive with the C-terminal 24 amino acid residues of N-cadherin, J Cell Sci, 97, 607, 10.1242\u002Fjcs.97.4.607\nCrittenden, 1991\nNapolitano, 1991, Molecular characterization of B-cadherin, a novel chick cadherin, J Cell Biol, 113, 893, 10.1083\u002Fjcb.113.4.893\nSuzuki, 1991, Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue, Cell Reg, 2, 261, 10.1091\u002Fmbc.2.4.261\nRanscht, 1991, T-cadherin, a novel member of the cadherin family in the nervous system lacks conserved cytoplasmic sequences, Neuron, 10.1016\u002F0896-6273(91)90291-7\nEdelman, 1987, Cellular expression of liver and neural cell adhesion molecules after transfection of their cDNAs results in specific cell-cell binding, 84, 8502\nMiyatani, 1989, Neural cadherin: role in selective cell-cell adhesion, Science, 24, 631, 10.1126\u002Fscience.2762814\nNose, 1988, Expressed recombinant cadherins mediate sorting in model systems, Cell, 54, 993, 10.1016\u002F0092-8674(88)90114-6\nNose, 1990, Localization of specificity determining sites in cadherin cell adhesion molecules, Cell, 61, 147, 10.1016\u002F0092-8674(90)90222-Z\nBlaschuk, 1990, Identification of a cadherin cell adhesion recognition sequence, Dev Biol, 139, 227, 10.1016\u002F0012-1606(90)90290-Y\nOzawa, 1990, Single amino acid substitutions in one Ca2+-binding site of uvomorulin abolish the adhesive function, Cell, 63, 1033, 10.1016\u002F0092-8674(90)90506-A\nOzawa, 1990, Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin, J Cell Biol, 111, 1645, 10.1083\u002Fjcb.111.4.1645\nHirano, 1987, Calcium-dependent cell-cell adhesion molecules (cadherins): subclass specificities and possible involvement of actin bundles, J Cell Biol, 105, 2501, 10.1083\u002Fjcb.105.6.2501\nOzawa, 1990, Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule, 87, 4246\nNagafuchi, 1988, Cell binding function of E-cadherin is regulated by the cytoplasmic domain, EMBO J, 7, 3679, 10.1002\u002Fj.1460-2075.1988.tb03249.x\nNagafuchi, 1989, Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein is functionally associated with a specific region of the cytoplasmic domain of E-cadherin, Cell Reg, 1, 37, 10.1091\u002Fmbc.1.1.37\nOzawa, 1989, The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species, EMBO J, 8, 1711, 10.1002\u002Fj.1460-2075.1989.tb03563.x\nKemler, 1989, Uvomorulin-catenin complex: cytoplasmic anchorage of a Ca2+-dependent cell adhesion molecule, BioEssays, 11, 88, 10.1002\u002Fbies.950110403\nMcNeill, 1990, Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity, Cell, 62, 309, 10.1016\u002F0092-8674(90)90368-O\nNelson, 1990, Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin on Madin-Darby canine kidney epithelial cells, J Cell Biol, 110, 349, 10.1083\u002Fjcb.110.2.349\nGeiger, 1989, Cytoskeleton-associated cell contacts, Curr Opin Cell Biol, 1, 103, 10.1016\u002FS0955-0674(89)80045-6\nVolberg, 1991, Modulation of intercellular adherens-type junctions and tyrosine phosphorylation of their components in RSV-transformed cultured chick lens cells, Cell Reg, 2, 105, 10.1091\u002Fmbc.2.2.105\nBalsamo, 1991, Antibodies to the retina N-acetylgalactosaminylphosphotransferase modulate N-cadherin mediated adhesion and uncouple the N-cadherin\u002Ftransferase complex from the actin containing cytoskeleton, J Cell Biol, 113, 429, 10.1083\u002Fjcb.113.2.429\nDuband, 1988, Spatial and temporal distribution of the adherens-junction-associated adhesion molecule A-CAM during avian embryogenesis, Development, 103, 325, 10.1242\u002Fdev.103.2.325\nHatta, 1987, Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos, Dev Biol, 120, 215, 10.1016\u002F0012-1606(87)90119-9\nThiery, 1984, Ontogenetic expression of cell adhesion molecules: L-CAM is found in epithelia derived from the three primary germ layers, Dev Biol, 102, 61, 10.1016\u002F0012-1606(84)90175-1\nLevi, 1991, The distribution of E-cadherin during Xenopus leavis development, Development, 111, 159, 10.1242\u002Fdev.111.1.159\nDetrick, 1990, The effects of N-cadherin misexpression on morphogenesis in Xenopus embryos, Neuron, 4, 493, 10.1016\u002F0896-6273(90)90108-R\nFujimori, 1990, Ectopic expression of N-cadherin perturbs histogenesis in Xenopus embryos, Development, 110, 97, 10.1242\u002Fdev.110.1.97\nKeynes, 1991, Contact inhibition of growth cone motility during neural development and regeneration, Semin Neurosci, 3, 321, 10.1016\u002F1044-5765(91)90049-T\nRanscht, 1989, Selective expression of a novel cadherin in the pathways of developing motor- and commissural axons, Soc Neurosci Abstr, 15, 959\nDodd, 1988, Axon guidance and the patterning of neuronal projections in vertebrates, Science, 242, 692, 10.1126\u002Fscience.3055291\nMatsunaga, 1988, Role of N-cadherin cell adhesion molecules in the histogenesis of neural retina, Neuron, 1, 289, 10.1016\u002F0896-6273(88)90077-3\nLeDourain, 1982\nAoyama, 1985, Cell adhesion mechanisms in gangliogenesis studied in avian embryo and in a model system, Cell Differ, 17, 247, 10.1016\u002F0045-6039(85)90499-3\nRanscht, 1991, T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo, Development, 111, 15, 10.1242\u002Fdev.111.1.15\nKeynes, 1988, Mechanisms of vertebrate segmentation, Development, 103, 413, 10.1242\u002Fdev.103.3.413\nDuband, 1987, Adhesion molecules during somitogenesis in the avian embryo, J Cell Biol, 104, 1361, 10.1083\u002Fjcb.104.5.1361\nVolk, 1990, Cleavage of A-CAM by endogenous proteinases in cultured lens cells and in developing chick embryos, Dev Biol, 139, 314, 10.1016\u002F0012-1606(90)90301-X\nSacristan, 1990, Evidence for the coexistence of two cadherin forms in the developing chicken nervous system, J Cell Biol, 11, 876\nTomaselli, 1988, N-cadherin and integrins: two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces, Neuron, 1, 33, 10.1016\u002F0896-6273(88)90207-3\nNeugebauer, 1988, N-cadherin, NCAM, and integrins promote retinal neurite outgrowth on astrocytes in vitro, J Cell Biol, 107, 1177, 10.1083\u002Fjcb.107.3.1177\nDrazba, 1990, The role of cell adhesion molecules in neurite outgrowth on Müller cells, Dev Biol, 138, 82, 10.1016\u002F0012-1606(90)90178-L\nBixby, 1988, Identification of the major proteins that promote neuronal process outgrowth on Schwann cells in vitro, J Cell Biol, 107, 353, 10.1083\u002Fjcb.107.1.353\nLetourneau, 1990, Nerve growth cone migration onto Schwann cells involves the calcium-dependent adhesion molecule, N-cadherin, Dev Biol, 138, 430, 10.1016\u002F0012-1606(90)90209-2\nBixby, 1987, Neurite outgrowth on muscle cell surfaces involves extracellular matrix receptors as well as Ca2+-dependent and -independent cell adhesion molecules, 84, 2555\nDoherty, 1991, Neurite outgrowth in response to transfected N-CAM and N-cadherin reveals fundamental differences in neuronal responsiveness to CAMs, Neuron, 6, 247, 10.1016\u002F0896-6273(91)90360-C\nBixby, 1990, Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth, J Cell Biol, 110, 1253, 10.1083\u002Fjcb.110.4.1253\nMatsunaga, 1988, Guidance of optic nerve fibres by N-cadherin adhesion molecules, Nature, 344, 62, 10.1038\u002F334062a0\nLemmon, 1991\nGaya-Gonzales, 1991, Antibodies to the retina N-acetylgalactosaminyl-phosphotransferase inhibit neurite outgrowth, J Neurosci Res, 10.1002\u002Fjnr.490290407",{"EN":126},"Cadherin cell adhesion molecules in vertebrate neural development",{"VOID":128},"10.1016\u002F1044-5765(91)90046-q","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F104457659190046Q",[131],{"id":132,"sortIndex":19,"researcher":18,"roles":133,"affiliations":134,"properties":143},"d9394c09-5fd5-4cb0-9e51-942136bf5d5e",[66],[135],{"id":18,"sortIndex":19,"affiliation":136,"properties":18},{"id":137,"createTime":138,"updateTime":138,"relativeEntities":139,"slug":18,"properties":140,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"542ae1ee-ea72-4b55-ad2f-789f5b723d20","2023-12-11T05:16:29.252+00:00",[],{"title":141},{"VI":142},"From the La Jolla Cancer Research Foundation, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA",{"title":144},{"VI":145},"Barbara Ranscht",{"url":129,"publisher":147,"properties":161},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":148,"slug":10,"properties":149,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":152,"manageAffiliations":153,"indexDatabases":154,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":150,"title":151},{"VOID":13},{"EN":15},[],[],[155],{"id":24,"indexDatabase":156,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":157,"label":158,"description":159,"key":34,"publicationTags":160,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":162,"pages":163},{"VOID":110},{"VOID":164},"285-296","1991-08-01",{"id":167,"createTime":168,"updateTime":169,"relativeEntities":170,"slug":171,"properties":172,"entityType":57,"verifyStatus":58,"verifyTime":179,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":180,"fullTextUrl":18,"authors":181,"publicationType":92,"publisherRelationship":222,"citationCount":18,"citationInfo":18,"publishDate":241,"publishYear":114,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"88dc890c-aaf1-4204-96c7-628d7c67eb91","2023-12-12T22:30:23.077+00:00","2025-01-06T23:46:34.471+00:00",[],"Aspects-of-the-molecular-pharmacology-of-GABAB-receptors",{"references":173,"title":175,"doi":177},{"VOID":174},"Hill, 1981, 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain, Nature, 290, 149, 10.1038\u002F290149a0\nCurtis, 1974, Central effects of β-(p-chlorophenyl)-γ-aminobutyric acid, Brain Res, 70, 493, 10.1016\u002F0006-8993(74)90257-1\nBowery, 1981, Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals, Eur J Pharmacol, 71, 53, 10.1016\u002F0014-2999(81)90386-1\nNewberry, 1984, Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells, Nature, 308, 450, 10.1038\u002F308450a0\nDutar, 1988, A physiological role for GABAB receptors in the central nervous system, Nature, 332, 156, 10.1038\u002F332156a0\nDavies, 1990, Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus, J Physiol, 424, 513, 10.1113\u002Fjphysiol.1990.sp018080\nGustaffson, 1990, Basic features of long-term potentiation in the hippocampus, Semin Neurosci, 2, 321\nBowery, 1980, Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor, Nature, 283, 92, 10.1038\u002F283092a0\nMaguire, 1990, (−)Baclofen inhibits the K+ -evoked release of endogenous aspartate glutamate and GABA from, rat hippocampal synaptosomes, 1990\nDel Rio, 1984, GABA inhibits the potassium-induced release of substance P from slices of rat spinal cord\nPrice, 1987, The location of GABAB receptor binding sites in mammalian spinal cord, Synapse, 1, 530, 10.1002\u002Fsyn.890010605\nBarber, 1978, GABAergic terminals are presynaptic to primary afferent terminals in the substantia gelatinosa of the rat spinal cord, Brain Res, 141, 35, 10.1016\u002F0006-8993(78)90615-7\nFox, 1978, Action of baclofen on mammalian synaptic transmission, Neuroscience, 3, 495, 10.1016\u002F0306-4522(78)90016-7\nPittaluga, 1987, Studies on 3H GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type, Eur J Pharmacol, 144, 45, 10.1016\u002F0014-2999(87)90007-0\nMinchin MCW, White R (1989) European Patent no. 345068\nSwartzwelder, 1987, Seizure-like events in brain slices: suppression by interictal activity, Brain Res, 410, 362, 10.1016\u002F0006-8993(87)90339-8\nFeltz, 1987, Intracellular effectors and modulators of GABAA and GABAB receptors: a commentary, Biochimie, 69, 395, 10.1016\u002F0300-9084(87)90031-9\nBowery, 1986, GABAB receptor activation inhibits the increase in nerve terminal Ca2+ induced by depolarization, Br J Pharmacol, 87, 37P\nStirling, 1989, The effect of GABAB receptor agonists and antagonists on potassium-stimulated [Ca2+]i in rat brain synaptosomes, Neuropharmacology, 28, 699, 10.1016\u002F0028-3908(89)90153-6\nBowery, 1989, GABA receptor characterization and localization in mammalian brain, 24\nHarrison, 1990, Presynaptic GABAB receptors on rat hippocampal neurons, 207\nKarlsson, 1988, Phaclofen: a GABAB blocker reduces long-duration inhibition in the neocortex, Eur J Pharmacol, 148, 485, 10.1016\u002F0014-2999(88)90136-7\nSoltesz, 1988, The GABAB antagonist phaclofen inhibits the late K+-dependent i.p.s.p. in cat and rat thalamic and hippocampal neurones, Brain Res, 448, 351, 10.1016\u002F0006-8993(88)91275-9\nThalmann, 1988, Evidence that guanosine triphosphate (GTP)-binding proteins control a synaptic response in brain: Effect of pertussis toxin and GTPγS on the late inhibitory postsynaptic potential of hippocampal CA3 neurons, J Neurosci, 8, 4589, 10.1523\u002FJNEUROSCI.08-12-04589.1988\nAsano, 1985, Prevention of the agonist binding to γ-aminobutyric acid B receptors by guanine nucleotides and islet-activating protein, pertussis toxin, in bovine cerebral cortex, J Biol Chem, 260, 12653, 10.1016\u002FS0021-9258(17)38921-4\nXu, 1986, Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: blockade by islet-activating protein, J Pharmac Exp Ther, 239, 568\nBowery, 1989, Neurochemistry and autoradiography of GABAB receptors in mammalian brain: second messenger system(s), 159\nHill, 1985, GABAB receptor modulation of adenylate cyclase activity in rat brain slices, Br J Pharmacol, 84, 249\nWojcik, 1989, Islet-activating protein inhibits the β-adrenergic receptor facilitation elicited by γ-aminobutyric acidB receptors, J Neurochem, 53, 753, 10.1111\u002Fj.1471-4159.1989.tb11769.x\nBowery, 1987, GABAA and GABAB receptor site distribution in the rat central nervous system, Neuroscience, 20, 365, 10.1016\u002F0306-4522(87)90098-4\nLloyd, 1985, Upregulation of γ-aminobutyric acid (GABAB) binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock, J Pharmac Exp Ther, 235, 191\nCross, 1988, Effects of chronic oral administration of the antidepressants desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5HT2 binding site changes, Br J Pharmacol, 93, 331, 10.1111\u002Fj.1476-5381.1988.tb11438.x\nPratt, 1990, Autoradiographic analysis of GABAB receptors in rat frontal cortex following chronic antidepressant administration, 319\nChu, 1990, Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study, Neuroscience, 34, 341, 10.1016\u002F0306-4522(90)90144-S\nBagetta, 1990, Tetanus toxin produces neuronal loss and a reduction in GABAA but not GABAB binding sites in rat hippocampus, Neurosci Lett, 109, 7, 10.1016\u002F0304-3940(90)90529-I\nBagetta, 1991, Hippocampal damage produced by tetanus toxin in rats can be prevented by lesioning CA1 pyramidal cell excitatory afferents, Neurosci Lett, 123, 32, 10.1016\u002F0304-3940(91)90151-I\nBagetta, 1990, Prevention by the NMDA receptor antagonist MK801 of neuronal loss produced by tetanus toxin in the rat hippocampus, Br J Pharmacol, 101, 776, 10.1111\u002Fj.1476-5381.1990.tb14156.x\nBagetta, 1991, CGP 37849, a competitive NMDA receptor antagonist, prevents the behavioural and neurodegenerative effects of tetanus toxin in rat hippocampus, Mol Neuropharmacol\nPenn, 1989, Intrathecal baclofen for severe spinal spasticity, N Engl J Med, 320, 1517, 10.1056\u002FNEJM198906083202303\nChapman, 1991, GABAergic mechanisms in the pulmonary system\nBittiger, 1990, Biochemistry, electrophysiology and pharmacology of a new GABAB antagonist: CGP 35348, 47\nAndrade, 1986, A G-protein couples serotonin and GABAB receptors to the same channels in hippocampus, Science, 234, 1261, 10.1126\u002Fscience.2430334\nDutar, 1988, Pre- and post-synaptic GABAB receptors in the hippocampus have different pharmacological properties, Neuron, 1, 585, 10.1016\u002F0896-6273(88)90108-0\nDolphin, 1990, GABAB-mediated inhibition of calcium currents: a possible role in presynaptic inhibition, 259\nOng, 1990, 3-aminopropanephosphinic acid is a potent agonist at peripheral and central presynaptic GABAB receptors, Brain Res, 526, 138, 10.1016\u002F0006-8993(90)90260-I\nOhmori, 1990, Solubilization and partial purification of GABAB receptor from bovine brain, Biochem Biophys Res Commun, 172, 22, 10.1016\u002FS0006-291X(05)80167-6\nSchofield, 1987, Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super family, Nature, 328, 221, 10.1038\u002F328221a0\nSekiguchi, 1990, GABAB receptors expressed in Xenopus oocytes by guineapig cerebral mRNA are functionally coupled with Ca++- dependent Cl− channels and with K+ channels, through GTP-binding proteins, Mol Brain Res, 8, 301, 10.1016\u002F0169-328X(90)90043-D\nBonanno, 1989, GABAB autoreceptors in rat cortex synaptosomes: response under different depolarising and ionic conditions, Eur J Pharmacol, 172, 41, 10.1016\u002F0922-4106(89)90043-6\nTaniyama, 1990, Expression of the GABAB receptor in Xenopus oocytes and inhibition of the response by activation of protein kinase C, FEBS, 222",{"EN":176},"Aspects of the molecular pharmacology of GABAB receptors",{"VOID":178},"10.1016\u002F1044-5765(91)90021-f","2025-01-06T23:46:34.470+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F104457659190021F",[182,198,210],{"id":183,"sortIndex":184,"researcher":18,"roles":185,"affiliations":186,"properties":195},"804ef9a3-6d82-4a77-86ef-2b59963cb072",2,[66],[187],{"id":18,"sortIndex":19,"affiliation":188,"properties":18},{"id":189,"createTime":190,"updateTime":190,"relativeEntities":191,"slug":18,"properties":192,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"2e990237-f247-4196-b022-8e1f2b414a01","2023-12-12T22:30:23.214+00:00",[],{"title":193},{"VI":194},"From the Department of Pharmacology, The School of Pharmacy, 29\u002F39 Brunswick Square, London WC1N 1AX, UK",{"title":196},{"VI":197},"G.D. Pratt",{"id":199,"sortIndex":19,"researcher":18,"roles":200,"affiliations":201,"properties":207},"fe63b004-9bef-4813-a343-826e4cb44da2",[66],[202],{"id":18,"sortIndex":19,"affiliation":203,"properties":18},{"id":189,"createTime":190,"updateTime":190,"relativeEntities":204,"slug":18,"properties":205,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":206},{"VI":194},{"title":208},{"VI":209},"N.G. Bowery",{"id":211,"sortIndex":64,"researcher":18,"roles":212,"affiliations":213,"properties":219},"1278e436-b9d0-4aab-b69b-014e0e258478",[66],[214],{"id":18,"sortIndex":19,"affiliation":215,"properties":18},{"id":189,"createTime":190,"updateTime":190,"relativeEntities":216,"slug":18,"properties":217,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":218},{"VI":194},{"title":220},{"VI":221},"J.J. Maguire",{"url":180,"publisher":223,"properties":237},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":224,"slug":10,"properties":225,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":228,"manageAffiliations":229,"indexDatabases":230,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":226,"title":227},{"VOID":13},{"EN":15},[],[],[231],{"id":24,"indexDatabase":232,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":233,"label":234,"description":235,"key":34,"publicationTags":236,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":238,"pages":239},{"VOID":110},{"VOID":240},"241-249","1991-06-01",{"id":243,"createTime":244,"updateTime":245,"relativeEntities":246,"slug":247,"properties":248,"entityType":57,"verifyStatus":58,"verifyTime":245,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":253,"fullTextUrl":18,"authors":254,"publicationType":92,"publisherRelationship":270,"citationCount":18,"citationInfo":18,"publishDate":290,"publishYear":291,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"b7a5df6c-c0d8-4236-950b-68bfc2ff921b","2024-01-08T17:12:12.922+00:00","2025-01-03T23:41:28.937+00:00",[],"Neuronal-death-in-the-development-of-the-vertebrate-central-nervous-system",{"title":249,"doi":251},{"EN":250},"Neuronal death in the development of the vertebrate central nervous system",{"VOID":252},"10.1006\u002Fsmns.1994.1037","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576584710372",[255],{"id":256,"sortIndex":19,"researcher":18,"roles":257,"affiliations":258,"properties":267},"8d9859f0-abd0-46f1-aad0-ee0c1c8f0c32",[66],[259],{"id":18,"sortIndex":19,"affiliation":260,"properties":18},{"id":261,"createTime":262,"updateTime":262,"relativeEntities":263,"slug":18,"properties":264,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a3da942e-68c4-477d-8761-344e663e3400","2024-01-08T17:12:12.939+00:00",[],{"title":265},{"VI":266},"From the Institut d'Anatomie, Rue du Bugnon 9, 1005 Lausanne, Switzerland",{"title":268},{"VI":269},"Peter G.H. Clarke",{"url":253,"publisher":271,"properties":285},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":272,"slug":10,"properties":273,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":276,"manageAffiliations":277,"indexDatabases":278,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":274,"title":275},{"VOID":13},{"EN":15},[],[],[279],{"id":24,"indexDatabase":280,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":281,"label":282,"description":283,"key":34,"publicationTags":284,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":286,"pages":288},{"VOID":287},"6",{"VOID":289},"291-297","1994-10-01",1994,{"id":293,"createTime":294,"updateTime":295,"relativeEntities":296,"slug":297,"properties":298,"entityType":57,"verifyStatus":17,"verifyTime":295,"verifyNote":305,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":306,"fullTextUrl":18,"authors":307,"publicationType":92,"publisherRelationship":315,"citationCount":18,"citationInfo":18,"publishDate":335,"publishYear":336,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"d9fbe586-8b75-45d8-aa70-9cd2b180ee86","2024-01-29T21:04:08.107+00:00","2025-02-08T23:40:08.846+00:00",[],"Neurotrophin-production-in-the-brain",{"references":299,"title":301,"doi":303},{"VOID":300},"Barde, 1989, Trophic factors and neuronal survival, Neuron, 2, 1525, 10.1016\u002F0896-6273(89)90040-8\nLevi-Montalcini, 1987, The nerve growth factor 35 yr later, Science, 237, 1154, 10.1126\u002Fscience.3306916\nThoenen, 1987, The physiological function of nerve growth factor in the central nervous system, Rev Physiol Biochem Pharmacol, 109, 145, 10.1007\u002FBFb0031026\nBarde, 1982, Purification of a new neurotrophic factor from mammalian brian, EMBO J, 1, 549, 10.1002\u002Fj.1460-2075.1982.tb01207.x\nLeibrock, 1989, Molecular cloning and expression of brain-derived neurotrophic fator, Nature, 344, 339\nHohn, 1990, Identification and characterization of a novel member of the nerve growth factor\u002Fbrain-derived neurotrophic factor family, Nature, 344, 339, 10.1038\u002F344339a0\nMaisonpierre, 1990, Neurotrophin-3: a neurotrophic factor related to NGF and BDNF, Science, 247, 1446, 10.1126\u002Fscience.2321006\nErnfors, 1990, Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographicalexpression in the brain, 87, 5454\nRosenthal, 1990, Primary structure and biological activity of a novel human neurotrophic factor, Neuron, 4, 767, 10.1016\u002F0896-6273(90)90203-R\nKaisho, 1990, Cloning and expression of a cDNA encoding a novel human neurotrophic factor, FEMS, 266, 187\nJones, 1990, Molecular cloning of a human gene that is a member of the nerve growth factor family, 87, 8060\nHallböök, 1991, Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary, Neuron, 6, 845, 10.1016\u002F0896-6273(91)90180-8\nIp, 1992, Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution and receptor specificity, 89, 3060\nBerkemeier, 1991, Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB, Neuron, 7, 857, 10.1016\u002F0896-6273(91)90287-A\nMeakin, 1991, Molecular investigation on the high-affinity nerve growth factor receptor, Neuron, 6, 153, 10.1016\u002F0896-6273(91)90130-R\nSutter, 1979, Nerve growth factor receptors: characterization of two distinct classes of binding sites on chick embryo sensory ganglia cell, J Biol Chem, 254, 5972, 10.1016\u002FS0021-9258(18)50507-X\nJohnson, 1986, Expression and structure of the human NGF receptor, Cell, 47, 545, 10.1016\u002F0092-8674(86)90619-7\nRadeke, 1987, Gene transfer and molecular cloning of the rat nerve growth factor receptor, Nature, 325, 593, 10.1038\u002F325593a0\nKaplan, 1991, Tyrosine phosphorylation and tyrosine kinase activity of the irk protooncogene product induced by NGF, Nature, 350, 158, 10.1038\u002F350158a0\nKlein, 1991, The trk proto-oncogene encodes a receptor for nerve growth factor, Cell, 65, 189, 10.1016\u002F0092-8674(91)90419-Y\nSoppet, 1991, The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinasc receptor, Cell, 65, 893, 10.1016\u002F0092-8674(91)90396-G\nSquinto, 1991, trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not for nerve growth factor, Cell, 65, 885, 10.1016\u002F0092-8674(91)90395-F\nKlein, 1991, The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3, Cell, 66, 395, 10.1016\u002F0092-8674(91)90628-C\nLambelle, 1991, trkC, annew member of the trk family of tyrosine protein kinases is a receptor for neurotrophin-3, Cell, 66, 96\nGrimes, 1993, Neurotrophin signaling in the nervous system, Semin Neurosci, 5, 239, 10.1016\u002FS1044-5765(05)80029-6\nShelton, 1984, Expression of the nerve growth factor gene correlates with the density of sympathetic innervation in effector organ, 81, 7951\nKorsching, 1985, Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation, EMBO J, 4, 1389, 10.1002\u002Fj.1460-2075.1985.tb03791.x\nWhittemore, 1986, Developmental and regional expression of nerve growth factor messenger RNA and protein in the rat central nervous system, 83, 817\nShelton, 1986, Studies on the expression of β nerve growth factor (NGF) in the central nervous system: level and regional distribution of NGF mRNA suggests thatNGF function as a trophic factor for several distinct populations of neurons, 83, 2714\nGoedert, 1986, Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effect in the rat brain and levels in Alzheimer's disease, Mol Brain Res, 387, 85, 10.1016\u002F0169-328X(86)90023-9\nRennert, 1986, Nerve growth factor mRNA in brain: localization by in situ hybridization, Biochem Biophys Res Comm, 138, 813, 10.1016\u002FS0006-291X(86)80569-1\nAyer-LeLievre, 1988, Expression of the β-nerve growth factor gene in hippocampal neurons, Science, 240, 1339, 10.1126\u002Fscience.2897715\nWhittemore, 1988, Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus, J Neurosci Res, 20, 403, 10.1002\u002Fjnr.490200402\nGall, 1989, Limbic seizures increase neuronal production of messenger RNA for nerve growth factor, Science, 245, 758, 10.1126\u002Fscience.2549634\nErnfors, 1990, Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family, Neuron, 5, 511, 10.1016\u002F0896-6273(90)90090-3\nGuthrie, 1991, Differential expression of mRNAs for the NGF family of neurotrophic factors in the adult rat central olfactory system, J Comp Neurol, 313, 95, 10.1002\u002Fcne.903130107\nLauterborn, 1991, Nerve growth factor mRNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain, J Comp Neurol, 306, 439, 10.1002\u002Fcne.903060308\nLu, 1991, NGF gene expression in actively growing brain glia, J Neurosci, 11, 318, 10.1523\u002FJNEUROSCI.11-02-00318.1991\nHofer, 1990, Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain, EMBO J, 9, 2459, 10.1002\u002Fj.1460-2075.1990.tb07423.x\nTimmusk, 1993, Multiple promoters mediate tissue-specific expression of the rat BDNF gene, Neuron, 10, 10.1016\u002F0896-6273(93)90335-O\nPhillips, 1990, Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons, Science, 250, 290, 10.1126\u002Fscience.1688328\nGall, 1992, Brainderived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons, Mol Cell Neurosci, 3, 56, 10.1016\u002F1044-7431(92)90009-Q\nWetmore, 1990, Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization, Exp Neurol, 109, 141, 10.1016\u002F0014-4886(90)90068-4\nWetmore, 1991, Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualized with nati-peptide antibodies, 88, 9843\nMaisonpierre, 1990, NT-3, BDNF and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression, Neuron, 5, 501, 10.1016\u002F0896-6273(90)90089-X\nTimmusk, 1993, Widespread and developmentally regulated expression of neurotrophin-4 messenger RNA in rat brain and peripheral tissues, Eur J Neurosci, 10.1111\u002Fj.1460-9568.1993.tb00526.x\nKlein, 1989, trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development, EMBO J, 8, 3701, 10.1002\u002Fj.1460-2075.1989.tb08545.x\nMerlio, 1992, Molecular cloning of rat trkC and identification of cells expressing mRNAs for members of the trk family in the rat central nervous system, Neurosci, 51, 513, 10.1016\u002F0306-4522(92)90292-A\nKokaia, 1993\nKaisho, 1991, Regional expression of the nerve growth factor gene family in rat brain during development, Biochem Biophys Res Comm, 174, 379, 10.1016\u002F0006-291X(91)90531-B\nLarge, 1986, Nerve growth factor gene expression in the developing rat brain, Science, 234, 352, 10.1126\u002Fscience.3764415\nLu, 1989, Expression of NGF and NGF receptor in the developing brain: evidence for local delivery and action of NGF, Exp Neurol, 104, 191, 10.1016\u002F0014-4886(89)90029-0\nMobley, 1989, Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen, Neuron, 3, 655, 10.1016\u002F0896-6273(89)90276-6\nFriedman, 1991, In situ hybridization reveals both transient and persistent expression of HDNT\u002FNT-3 mRNA in the rat brain during postnatal development, J Neurosci, 11, 1577, 10.1523\u002FJNEUROSCI.11-06-01577.1991\nErnfors, 1992, Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development, Eur J Neurosci, 4, 1140, 10.1111\u002Fj.1460-9568.1992.tb00141.x\nFriedman, 1991, Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain, Eur J Neurosci, 3, 688, 10.1111\u002Fj.1460-9568.1991.tb00854.x\nHyman, 1991, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature, 350, 230, 10.1038\u002F350230a0\nKnusel, 1991, Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3, 88, 961\nErnfors, 1990, Cholinergic neurons of the nucleus basal express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type, Dementia, 1, 138\nPhillips, 1991, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron, 7, 695, 10.1016\u002F0896-6273(91)90273-3\nWetmore, 1992\nAlderson, 1990, Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture, Neuron, 5, 297, 10.1016\u002F0896-6273(90)90166-D\nJsackson, 1991, BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF, Neuron, 6, 937, 10.1016\u002F0896-6273(91)90234-Q\nZafra, 1990, Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non NMDA glutamate receptors, EMBO J, 9, 3545, 10.1002\u002Fj.1460-2075.1990.tb07564.x\nGall, 1991, Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus, Mol Brain Res, 9, 113, 10.1016\u002F0169-328X(91)90136-L\nBallarin, 1991, Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain, Exp Neurol, 114, 35, 10.1016\u002F0014-4886(91)90082-N\nRocamora, 1992, Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3, inthe rat hippocampus, Mol Brain Res, 13, 27, 10.1016\u002F0169-328X(92)90041-9\nErnfors, 1991, Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis, Neuron, 7, 165, 10.1016\u002F0896-6273(91)90084-D\nLindvall, 1992, Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the adult rat brain followingcerebral ischemia and hypoglycemic coma, 89, 648\nMerlio, 1992, Increased production of the trkB proteintyrosine kinase receptor after brain insults, Neuron, 10\nCeccatelli, 1991, Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor and neurotrophin 3 in the rat brain after colchicinetreatment, 88, 10352",{"EN":302},"Neurotrophin production in the brain",{"VOID":304},"10.1016\u002Fs1044-5765(05)80028-4","Author affiliation is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576505800284",[308],{"id":309,"sortIndex":19,"researcher":18,"roles":310,"affiliations":311,"properties":312},"ba4c0202-f6ad-47ac-97e7-480fe83e4cd4",[66],[],{"title":313},{"VI":314},"Håkan Persson",{"url":306,"publisher":316,"properties":330},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":317,"slug":10,"properties":318,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":321,"manageAffiliations":322,"indexDatabases":323,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":319,"title":320},{"VOID":13},{"EN":15},[],[],[324],{"id":24,"indexDatabase":325,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":326,"label":327,"description":328,"key":34,"publicationTags":329,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":331,"pages":333},{"VOID":332},"5",{"VOID":334},"227-237","1993-08-01",1993,{"id":338,"createTime":339,"updateTime":340,"relativeEntities":341,"slug":342,"properties":343,"entityType":57,"verifyStatus":58,"verifyTime":350,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":351,"fullTextUrl":18,"authors":352,"publicationType":92,"publisherRelationship":383,"citationCount":18,"citationInfo":18,"publishDate":403,"publishYear":404,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"4f08c1a3-a2e2-404d-895b-a4dbde1842dc","2023-11-30T22:44:58.911+00:00","2024-12-15T23:30:51.955+00:00",[],"Clinical-Medications-Development-for-Opiate-Addiction-Focus-on-Nonopioids-and-Opioid-Antagonists-for-the-Amelioration-of-Opiate-Withdrawal-Symptoms-and-Relapse-Prevention",{"references":344,"title":346,"doi":348},{"VOID":345},"O'Brien, 1996, Myths about the treatment of addiction, Lancet, 347, 237, 10.1016\u002FS0140-6736(96)90409-2\nMendelson, 1996, Management of cocaine abuse and dependence, N. Eng. J. Med., 334, 965, 10.1056\u002FNEJM199604113341507\nMcLellan, 1993, The effects of psychosocial services in substance abuse treatment, J. Am. Med. Assoc., 269, 1953, 10.1001\u002Fjama.1993.03500150065028\nHerman, 1995, The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: Medication development issues for opiate addiction, Neuropsychopharmacology, 13, 269, 10.1016\u002F0893-133X(95)00140-9\nKreek, 1997, Clinical update of opioid agonist and partial agonist medications for the maintenance treatment of opiate addiction, Semin. Neurosci., 9, 10.1006\u002Fsmns.1997.0114\nKleber, 1982, The treatment of narcotic withdrawal: a historical review, J. Clin. Psychiatr., 43, 30\nMattick, 1996, Are detoxification programmes effective?, Lancet, 347, 97, 10.1016\u002FS0140-6736(96)90215-9\nBall, 1991\nNestler, 1997, Molecular mechanisms underlying opiate addiction: implications for medications development, Semin. Neurosci., 9, 10.1006\u002Fsmns.1997.0109\nAghajanian, 1982, Central noradrenergic neurons: a locus for the functional interplay between alpha-2-adrenoreceptors and opiate receptors, J. Clin. Psychiatr., 43, 20\nGold, 1993, Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. Recent Advances in Addictive Disorders, Psychiatr. Clin. North Am., 16, 61, 10.1016\u002FS0193-953X(18)30190-4\nRoth, 1982, Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: Biochemical studies in rodents and primates, J. Clin. Psychiatr., 43, 42\nJaffe, 1995, Pharmacological treatment of opioid dependence: current techniques and new findings, Psychiatr. Ann., 25, 369, 10.3928\u002F0048-5713-19950601-09\nAston-Jones, 1993, Opiates influence locus coeruleus neurons by potent indirect and direct actions\nGold, 1978, Clonidine blocks acute opiate withdrawal symptoms, Lancet, 1, 599, 10.1016\u002FS0140-6736(78)92823-4\nGold, 1980, Opiate withdrawal using clonidine: A safe, effective, and rapid nonopiate treatment, JAMA, 243, 343, 10.1001\u002Fjama.1980.03300300021018\nCharney, 1981, The clinical use of clonidine in abrupt withdrawal from methadone, Arch. Gen. Psychiatr., 38, 1273, 10.1001\u002Farchpsyc.1981.01780360089010\nUhde, 1980, Clonidine suppresses the opiate abstinence syndrome without clonidine-withdrawal symptoms: A blind inpatient study, Psychiatr. Res., 2, 37, 10.1016\u002F0165-1781(80)90005-0\nJasinski, 1985, Clonidine in morphine withdrawal. Differential effects on signs and symptoms, Arch. Gen. Psychiatr., 42, 1063, 10.1001\u002Farchpsyc.1985.01790340041006\nGhodse, 1994, Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction, Br. J. Psychiatr., 165, 370, 10.1192\u002Fbjp.165.3.370\nKahn, 1997, Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital, Drug Alcohol Depend., 44, 57, 10.1016\u002FS0376-8716(96)01316-6\nWashton, 1981, Clonidine in opiate withdrawal: Review and appraisal of clinical findings, Pharmacotherapy, 1, 140, 10.1002\u002Fj.1875-9114.1981.tb03561.x\nRiordan, 1980, Rapid opiate detoxification with clonidine and naloxone, Lancet, 1, 1079, 10.1016\u002FS0140-6736(80)91516-0\nCharney, 1982, Clonidine and naltrexone: A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy, Arch. Gen. Psychiatr., 39, 1327, 10.1001\u002Farchpsyc.1982.04290110077013\nCharney, 1986, The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone, Am. J. Psychiatr., 143, 831, 10.1176\u002Fajp.143.7.831\nGerra, 1995, Clonidine and opiate receptor antagonists in the treatment of heroin addiction, J. Subst. Abuse Treat., 12, 35, 10.1016\u002F0740-5472(94)00077-8\nKleber, 1987, Clonidine and naltrexone in the outpatient treatment of heroin withdrawal, Am. J. Drug Alcohol Abuse, 13, 1, 10.3109\u002F00952998709001497\nMarjamäki, 1993, Use of recombinant human alpha-2-adrenoreceptors to characterize subtype selectivity of antagonist binding, Eur. J. Pharmacol., 246, 219, 10.1016\u002F0922-4106(93)90034-7\nUhlen, 1991, Delineation of rat kidney alpha-2A and alpha 2B-adrenoreceptors with [3, Eur. J. Pharmacol., 202, 235\nArnsten, 1988, The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive adverse effects: Evidence for alpha-2 receptor subtypes, J. Neurosci., 8, 4287, 10.1523\u002FJNEUROSCI.08-11-04287.1988\nShearman, 1980, Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat, Pharm. Biochem. Behav., 12, 573, 10.1016\u002F0091-3057(80)90191-4\nGold, 1981, Opiate detoxification with lofexidine, Drug Alcohol Depend., 8, 307, 10.1016\u002F0376-8716(81)90040-5\nWashton, 1982, Lofexidine in abrupt methadone withdrawal, Psychopharmacol. Bull., 18, 220\nWashton, 1983, Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects, J. Clin. Psychiatr., 44, 335\nBearn, 1996, Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal, Drug Alcohol Depend., 43, 87, 10.1016\u002FS0376-8716(96)01289-6\nGabilondo, 1994, Mu-opioid receptor and alpha 2-adrenoreceptor agonist binding sites in the postmortem brain of heroin addicts, Psychopharmacol. Berlin, 115, 135, 10.1007\u002FBF02244763\nGerra, 1994, Alpha-2-adrenoreceptor sensitivity in heroin addicts with and without previous attention deficit disorder\u002Fhyperactivity and conduct disorder, Neuropsychobiology, 30, 15, 10.1159\u002F000119129\nInturrisi, 1997, Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence, Semin. Neurosci., 9, 10.1006\u002Fsmns.1997.0111\nHaigler, 1994, NMDA receptor antagonists: neurotoxicity evaluation, Psychopharmacol. Bull., 30, 525\nAuer, 1994, The nature and time course of neuronal vacuolation induced by the NMDA antagonist MK-801, Acta. Neuropathol. (Berlin, 87, 1, 10.1007\u002FBF00386248\nOlney, 1989, Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science, 244, 1360, 10.1126\u002Fscience.2660263\nRasmussen, 1991, NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal, Eur. J. Pharmacol., 197, 9, 10.1016\u002F0014-2999(91)90358-W\nKoek, 1990, Selective blockade ofNd, J. Pharmacol. Exp. Ther., 252, 349\nHerrling, 1994, D-CPPene (SDZ EAA 494), A competitive NMDA antagonist: results from animal models and first results in humans, Neuropsychopharmacology, 10, 591S\nVaupel, 1995, Nitric oxide synthase inhibitors: Preclinical studies of potential use for treatment of opioid withdrawal, Neuropsychopharmacology, 13, 315, 10.1016\u002F0893-133X(95)00138-4\nChen, 1992, Open channel block ofNd, J. Neurosci., 12, 4427, 10.1523\u002FJNEUROSCI.12-11-04427.1992\nMcQuay, 1994, Dextromethorphan for the treatment of neuropathic pain: A double-blind randomised controlled crossover trial with integral n-of-1 design, Pain, 59, 127, 10.1016\u002F0304-3959(94)90056-6\nNelson, 1997, High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia, Neurology, 48, 1212, 10.1212\u002FWNL.48.5.1212\nKoyuncuoglu, 1990, The treatment of heroin addicts with dextromethorphan: A double-blind comparison of dextromethorphan with chlorpromazine, Int. J. Clin. Pharmacol. Ther. Toxicol., 28, 147\nRosen, 1996, A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal, Eur. J. Pharmacol., 307, 251, 10.1016\u002F0014-2999(96)00249-X\nM. I. Rosen, F. A. Hameedi, H. R. Pearsall, T. R. Kosten, 1996b, The effect of lamotrigine on naloxone-precipitated opiate withdrawal\nChildress, 1992, Classically conditioned factors in drug dependence, 56\nPulvirenti, 1997, Dextromethorphan reduces intravenous cocaine self-administration in the rat, Eur. J. Pharmacol., 321, 279, 10.1016\u002FS0014-2999(96)00970-3\nPrzegalinski, 1996, Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors, Pharm. Biochem. Behav., 54, 73, 10.1016\u002F0091-3057(95)02157-4\nPopik, 1996, The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence, Pharmacol. Biochem. Behav., 53, 791, 10.1016\u002F0091-3057(95)02163-9\nZeise, 1993, Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors, Eur. J. Pharmacol., 231, 47, 10.1016\u002F0014-2999(93)90682-8\nSass, 1996, Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence, Arch. Gen. Psychiatr., 53, 673, 10.1001\u002Farchpsyc.1996.01830080023006\nLitten, 1996, Pharmacotherapies for alcohol problems: A review of research with focus on developments since 1991, Alcohol Clin. Exp. Res., 20, 859, 10.1111\u002Fj.1530-0277.1996.tb05264.x\nCostall, 1992, Profile or action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset, J. Pharmacol. Exp. Ther., 262, 90\nHerman, 1981, Ascending endorphinergic inhibition of distress vocalization, Science, 211, 1060, 10.1126\u002Fscience.7466377\nRatey, 1991, Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple-baseline, placebo lead-in study, J. Clin. Psychiatr., 52, 159\nDelle-Chiaie, 1995, Assessment of the efficacy of buspirone in patients affects by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: A placebo-controlled, double-blind study, J. Clin. Psychopharmacol., 15, 12, 10.1097\u002F00004714-199502000-00003\nO'Hanlon, 1991, Review of buspirone's effects on human performance and related variables, Eur. Neuropsychopharmacol., 1, 489, 10.1016\u002F0924-977X(91)90002-C\nM. D. Aceto, E. R. Bowman, L. S. Harris, E. L. May, 1992, Dependence studies of new compounds in the rhesus monkey and mouse (1991). Problems of Drug Dependence 1991, Proceedings of the 53rd Annual Scientific Meeting, L. Harris, 554, 555, The Committee on Problems of Drug Dependence, Inc, Rockville, MD\nBalster, 1990, Abuse potential of buspirone and related drugs, J. Clin. Psychopharmacol., 10, 31S, 10.1097\u002F00004714-199006001-00007\nBatki, 1990, Buspirone in drug users with AIDS or AIDS-related complex, J. Clin. Psychopharmacol., 10, 111S, 10.1097\u002F00004714-199006001-00018\nCurzon, 1991, Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding, Adv. Exp. Med. Biol., 294, 377, 10.1007\u002F978-1-4684-5952-4_35\nKranzler, 1996, Evaluation and treatment of anxiety symptoms and disorders in alcoholics, J. Clin. Psychiatr., 57, 12\nKnapp, 1992, Effects of gepirone on ethanol consumption, exploratory behavior, and motor performance in rats, Drug Dev. Res., 26, 319, 10.1002\u002Fddr.430260310\nTomkins, 1994, Low doses of the 5-HT1A, Psychopharmacology, 115, 173, 10.1007\u002FBF02244769\nTollefson, 1992, Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone), J. Clin. Psychopharmacol., 12, 19, 10.1097\u002F00004714-199202000-00004\nCinciripini, 1995, A placebo-controlled evaluation of the effects of buspirone on smoking cessation: Differences between high- and low-anxiety smokers, J. Clin. Psychopharmacol., 15, 182, 10.1097\u002F00004714-199506000-00006\nMaremmani, 1995, Fluoxetine improves outcome in addicted patients treated with opioid antagonists, Am. J. Addictions, 4, 267\nMurphy, 1988, Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol-preferring P line of rats, Alcohol, 5, 283, 10.1016\u002F0741-8329(88)90066-3\nHollister, 1978, Clinical evaluation of naltrexone treatment of opiate-dependent individuals: Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists, Arch. Gen. Psychiatr., 35, 335, 10.1001\u002Farchpsyc.1978.01770270085008\nStanfa, 1994, Cholecystokinin and morphine analgesia: variations on a theme, TiPS, 15, 65\nFaris, 1983, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science, 219, 310, 10.1126\u002Fscience.6294831\nDourish, 1988, Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718, Eur. J. Pharmacol., 147, 469, 10.1016\u002F0014-2999(88)90183-5\nDourish, 1990, The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat, Eur. J. Pharmacol., 176, 35, 10.1016\u002F0014-2999(90)90129-T\nWatkins, 1984, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, Science, 224, 395, 10.1126\u002Fscience.6546809\nWiesenfeld-Hallin, 1990, PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes, Proc. Natl. Acad. Sci. USA, 87, 7105, 10.1073\u002Fpnas.87.18.7105\nXu, 1996, L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: Electrophysiological and behavioural studies, Neuropeptides, 30, 203, 10.1016\u002FS0143-4179(96)90088-8\nO'Neill, 1990, Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey, Brain Res., 534, 287, 10.1016\u002F0006-8993(90)90141-W\nZhou, 1993, Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB, Eur. J. Pharmacol., 234, 147, 10.1016\u002F0014-2999(93)90948-H\nPanerai, 1987, Dissociation of tolerance and dependence to morphine: A possible role of cholecystokinin, Brain Res., 410, 52, 10.1016\u002FS0006-8993(87)80019-7\nBarber, 1989, The role of CCK caerulein, and CCK antagonists in nociception, Pain, 39, 307, 10.1016\u002F0304-3959(89)90045-6\nMaldonado, 1994, Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats, Pharmacol. Biochem. Behav., 48, 363, 10.1016\u002F0091-3057(94)90539-8\nHoffmann, 1994, The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats, NeuroReport, 5, 2565, 10.1097\u002F00001756-199412000-00040\nTiseo, 1993, Attenuation and reversal of morphine tolerance by the competitiveNd, J. Pharmacol. Exp. Ther., 264, 1090\nHendrie, 1993, The effects of CCKA and CCKB antagonists on activity in the black\u002Fwhite exploration model of anxiety in mice, Physiol. Behav., 54, 689, 10.1016\u002F0031-9384(93)90077-S\nPowell, 1991, Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys, Neuropeptides, 19, 75, 10.1016\u002F0143-4179(91)90085-W\nBradwejn, 1994, The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder, Arch. Gen. Psychiatr., 51, 486, 10.1001\u002Farchpsyc.1994.03950060050005\nKramer, 1995, A placebo-controlled trial of L-365,260, a CCKB antagonist in panic disorder, Biol. Psychiatr., 37, 462, 10.1016\u002F0006-3223(94)00190-E\nTokar, 1975, Determining what heroin means to heroin addicts, Dis. Nervous System, 36, 77\nLivingstone, 1988, Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan, Psychopharmacology, 94, 540, 10.1007\u002FBF00212852\nHartmann, 1991, Comparison of acetorphan with clonidine for opiate withdrawal symptoms, Am. J. Psychiatr., 148, 627, 10.1176\u002Fajp.148.5.627\nRoge, 1993, The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide, Scand. J. Gastroenterol., 28, 352, 10.3109\u002F00365529309090255\nYaksh, 1991, Effects of [Nll, J. Pharmacol. Exp. Ther., 256, 1033\nRoques, 1995, Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction, NIDA Res. Monogr., 147, 104\nFishman, 1973, Disposition of naloxone in normal and narcotic-dependent men, J. Pharmacol. Exp. Ther., 187, 575\nResnick, 1978, Naltrexone in the treatment of opiate dependence, 321\nResnick, 1974, Studies of EN-1639A (naltrexone): A new narcotic antagonist, Am. J. Psychiatr., 131, 646, 10.1176\u002Fajp.131.6.646\nO'Brien, 1978, Clinical pharmacology of narcotic antagonists, Annals of NY Academy of Sciences, 311, 232, 10.1111\u002Fj.1749-6632.1978.tb16779.x\nMartin, 1973, Naltrexone, an antagonist for the treatment of heroin dependence, Arch. Gen. Psychiatr., 28, 784, 10.1001\u002Farchpsyc.1973.01750360022003\nLee, 1988, Duration of occupancy of opiate receptors by naltrexone, J. Nuclear Med., 29, 1207\nLoimer, 1991, Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates, Am. J. Psychiatr., 148, 933, 10.1176\u002Fajp.148.7.933\nBrewer, 1988, Opioid withdrawal and naltrexone induction in 48–72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique, Br. J. Psychiatr., 153, 340, 10.1192\u002Fbjp.153.3.340\nGreenstein, 1984, Naltrexone: a clinical perspective, J. Clin. Psychiatr., 45, 25\nWashton, 1984, Naltrexone in addicted business executives and physicians, J. Clin. Psychiatr., 45, 39\nCornish, 1997, Naltrexone pharmacotherapy for opioid dependent federal probationers, J. Substance Abuse Treatment, 14, 1, 10.1016\u002FS0740-5472(97)00020-2\nGonzalez, 1988, Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence, Drugs, 35, 192, 10.2165\u002F00003495-198835030-00002\nH. Kranzler, 1996, Oral presentation—American College of Neuropsychopharmacology, San Juan, Puerto Rico\nMaggio, 1985, Naltrexone and human eating behavior: A dose-ranging inpatient trial in moderately obese men, Brain Res. Bull., 14, 657, 10.1016\u002F0361-9230(85)90115-7\nHahn, 1975, Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists, J. Med. Chem., 18, 259, 10.1021\u002Fjm00237a008\nDixon, 1986, Nalmefene: Intravenous safety and kinetics of a new opioid antagonist, Clin. Pharmacol. Ther., 39, 49, 10.1038\u002Fclpt.1986.9\nGal, 1986, Prolonged blockade of opioid effect with oral nalmefene, Clin. Pharmacol. Ther., 40, 537, 10.1038\u002Fclpt.1986.220\nKonieczko, 1988, Antagonism of morphine-induced respiratory depression with nalmefene, Br. J. Anaesth., 61, 318, 10.1093\u002Fbja\u002F61.3.318\nGlass, 1994, Comparison of potency and duration of action nalmefene and naloxone, Anesth. Analg., 78, 536, 10.1213\u002F00000539-199403000-00021\nBarsan, 1989, Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures, Am. J. Emerg. Med., 7, 155, 10.1016\u002F0735-6757(89)90128-9\nFudala, 1991, Human pharmacology and abuse potential of nalmefene, Clin. Pharmacol. Ther., 49, 300, 10.1038\u002Fclpt.1991.32\nMason, 1994, A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence, Alcoholism: Clin. Exp. Res., 18, 1162, 10.1111\u002Fj.1530-0277.1994.tb00098.x\nUlm, 1995, Opiates and alcohol self-administration in animals, J. Clin. Psychiatr., 56, 5\nJ. Volpicelli, A. Alterman, M. Hayashida, L. Muentz, C. P. O'Brien, Naltrexone and the treatment of alcohol dependence, Opioids, Bulimia and Alcoholism, L. D. Reid, 195, 214, Springer-Verlag, New York\nVolpicelli, 1992, Naltrexone in the treatment of alcohol dependence, Arch. Gen. Psychiatr., 49, 876, 10.1001\u002Farchpsyc.1992.01820110040006\nO'Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence, Arch. Gen. Psychiatr., 49, 881, 10.1001\u002Farchpsyc.1992.01820110045007",{"EN":347},"Clinical Medications Development for Opiate Addiction: Focus on Nonopioids and Opioid Antagonists for the Amelioration of Opiate Withdrawal Symptoms and Relapse Prevention",{"VOID":349},"10.1006\u002Fsmns.1997.0115","2024-12-15T23:30:51.954+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576597901159",[353,368],{"id":354,"sortIndex":19,"researcher":18,"roles":355,"affiliations":356,"properties":365},"06444aa8-4e7f-4862-a3b7-808f93383f8f",[66],[357],{"id":18,"sortIndex":19,"affiliation":358,"properties":18},{"id":359,"createTime":360,"updateTime":360,"relativeEntities":361,"slug":18,"properties":362,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9c69317b-c98b-420e-a0db-5bdb36642220","2023-11-30T22:44:58.933+00:00",[],{"title":363},{"VI":364},"Clinical Trials Branch, Medications Development Division, National Institute on Drug Abuse, National Institutes of Health, Rockville, Maryland, 20857",{"title":366},{"VI":367},"Barbara H. Herman",{"id":369,"sortIndex":64,"researcher":18,"roles":370,"affiliations":371,"properties":380},"28bef186-a3e0-4fe2-a247-deeaaa92cdd3",[66],[372],{"id":18,"sortIndex":19,"affiliation":373,"properties":18},{"id":374,"createTime":375,"updateTime":375,"relativeEntities":376,"slug":18,"properties":377,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"ddf2c73e-e901-42fc-94e2-41e68875a409","2023-11-30T22:44:58.939+00:00",[],{"title":378},{"VI":379},"Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104-6178",{"title":381},{"VI":382},"Charles P. O'Brien",{"url":351,"publisher":384,"properties":398},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":385,"slug":10,"properties":386,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":389,"manageAffiliations":390,"indexDatabases":391,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":387,"title":388},{"VOID":13},{"EN":15},[],[],[392],{"id":24,"indexDatabase":393,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":394,"label":395,"description":396,"key":34,"publicationTags":397,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":399,"pages":401},{"VOID":400},"9",{"VOID":402},"158-172","1997-01-01",1997,{"id":406,"createTime":407,"updateTime":408,"relativeEntities":409,"slug":410,"properties":411,"entityType":57,"verifyStatus":58,"verifyTime":408,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":418,"fullTextUrl":18,"authors":419,"publicationType":92,"publisherRelationship":447,"citationCount":18,"citationInfo":18,"publishDate":467,"publishYear":468,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"596f29fa-4489-4a3e-8295-1d7a73deee80","2023-12-13T18:46:25.314+00:00","2024-10-18T23:03:23.058+00:00",[],"Immunologic-responses-in-central-nervous-system-transplantation",{"references":412,"title":414,"doi":416},{"VOID":413},"Gash, 1984, Neural transplants in mammals: a historical overview, 1\nKinutani, 1986, Postnatal development of a demyelinating disease in avian spinal cord chimeras, Cell, 45, 307, 10.1016\u002F0092-8674(86)90395-8\nBjörklund, 1991, Neural transplantation: an experimental tool with clinical possibilities, Trends Neurosci, 14, 319, 10.1016\u002F0166-2236(91)90154-M\nBarker, 1977, Immunologically privileged sites, Adv Immunol, 25, 1, 10.1016\u002FS0065-2776(08)60930-X\nPerlow, 1979, Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system, Science, 20, 643, 10.1126\u002Fscience.571147\nHoffer, 1991, Ethical issues in brain-cell transplantation, Trends Neurosci, 14, 384, 10.1016\u002F0166-2236(91)90168-T\nHall, 1984, Cells mediating allograft rejection, Immunol Rev, 77, 31, 10.1111\u002Fj.1600-065X.1984.tb00717.x\nWilliams, 1968, Hyperacute renal homograft rejection in man, N Engl J Med, 27, 611, 10.1056\u002FNEJM196809192791201\nRivas, 1989, Evidence for involvement of the gamma delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones, J Immunol, 142, 1840, 10.4049\u002Fjimmunol.142.6.1840\nWong, 1984, Differential expression and regulation of major histocompatibility complex (MHC) products in neural cells of the human fetal brain, J Neuroimmunol, 18, 271\nLindahl, 1977, Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors, J Exp Med, 145, 508, 10.1084\u002Fjem.145.3.508\nLaRosa, 1985, Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts, Transplantation, 39, 480, 10.1097\u002F00007890-198505000-00004\nRosenberg, 1986, Analysis of T cell subsets in rejection of Kb mutant skin allografts differing at the class I MHC, Nature, 322, 829, 10.1038\u002F322829a0\nKaplan, 1984, Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products, Cell Immunol, 88, 193, 10.1016\u002F0008-8749(84)90064-9\nBrent, 1990, Immunologically privileged sites, 383\nBillingham, 1953, Studies on the problem of corneal homografts, 141, 392\nEbeling, 1914, Experimentelle Gehirntumoren bei mausen, Z Krebsforsch, 14, 151, 10.1007\u002FBF02137235\nMurphy, 1923, Conditions determining the transplantability of tissue in the brain, J Exp Med, 38, 183, 10.1084\u002Fjem.38.2.183\nNicholas, 1989, Immunologic considerations in transplantation to the central nervous system, 239\nMedawar, 1948, Immunity to homologous grafted skin III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye, Br J Exp Pathol, 29, 58\nPrineas, 1979, Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord, Science, 203, 1123, 10.1126\u002Fscience.424741\nWidner, 1988, Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites, Scand J Immunol, 28, 563, 10.1111\u002Fj.1365-3083.1988.tb01488.x\nRosenstein, 1987, Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules, Science, 235, 772, 10.1126\u002Fscience.2433767\nWidner, 1988, Immunological aspects of neural grafting in the mammalian central nervous system, 303\nHickey, 1991, T lymphocyte entry into the central nervous system, J Neurosci Res, 28, 254, 10.1002\u002Fjnr.490280213\nStoolman, 1989, Adhesion molecules controlling lymphocyte migration, Cell, 56, 907, 10.1016\u002F0092-8674(89)90620-X\nCannella, 1991, Adhesion-related molecules in the central nervous system: upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis, Lab Invest, 65, 23\nWilliams, 1980, Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues, Transplantation, 29, 274, 10.1097\u002F00007890-198004000-00002\nNicholas, 1987, Rejection of fetal neocortical neural transplants by H-2 incompatible mice, J Immunol, 139, 2275, 10.4049\u002Fjimmunol.139.7.2275\nSaltykow, 1905, Versuche uber gehirnreplantation, zugleich ein beitrag zur kenntniss reactiver vorgange an den zelligen gehirnelementen, Arch Psychiatr, 40, 329, 10.1007\u002FBF02071085\nBjörklund, 1982, Cross-species neural grafting in a rat model of Parkinson's disease, Nature, 298, 652, 10.1038\u002F298652a0\nFinsen, 1990, Immune reactions against intracerebral murine xenografts of fetal hippocampal tissue and cultured cortical astrocytes in the adult rat, 111\nPollack, 1990, MHC antigen expression and induced rejection of neural xenografts, 129\nInoue, 1985, Immunohistochemical studies on mouse cerebral cortex grafted into the third ventricle of rats treated with cyclosporin A, Neurosci Lett, 57, 289, 10.1016\u002F0304-3940(85)90507-5\nFinsen, 1988, Immunocyto-chemical characterization of the cellular immune response to intracerebral xenografts of brain tissue, 261\nSeiger, 1988, Human fetal catecholamine-containing tissues grafted intracranially to immuno-compromised rodent hosts, 449\nFreeman, 1988, Cross-species intracerebral grafting of embryonic swine dopaminergic neurons, 473\nMason, 1986, The fate of allogeneic neuronal tissue transplanted into the third ventricle of rodents, Neuroscience, 19, 685, 10.1016\u002F0306-4522(86)90292-7\nBrundin, 1988, Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behavior, and dopamine release, Exp Brain Res, 70, 192, 10.1007\u002FBF00271860\nBauer, 1983, Umschrittene MS therapie, Nervenarzt, 54, 400\nKnorr-Held, 1986, Sensitization against brain gangliosides after therapeutic swine brain implantation in a multiple sclerosis paient, J Neurol, 233, 54, 10.1007\u002FBF00313994\nHemaehuda, 1987, Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination, N Engl J Med, 316, 369, 10.1056\u002FNEJM198702123160703\nFreed, 1988, Intraventricular brain allografts and xenografts: studies of survival and rejection with and without systemic sensitization, 233\nSloan, 1990, The effect of site of transplantation and histocompatibility differences on the survival of neural tissue transplanted to the CNS of defined inbred rat strains, 141\nLindvalle, 1992, Transplantation of fetal dopamine neurons in Parkinson's disease: one year clinical and neurophysiological observations in two patients with putaminal implants, Ann Neurol, 31, 155, 10.1002\u002Fana.410310206\nFreed, 1990, Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease, 715\nNicholas, 1990, A role for CD8− T lymphocytes late in the rejection of intraventricular fetal neocortical fragment allografts in the mouse, 573\nPoltorak, 1991, BN rats do not reject F344 brain allografts even after systemic sensitization, Ann Neurol, 29, 377, 10.1002\u002Fana.410290408\nMassa, 1987, Hyper-inducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis, 80, 6019\nKlein, 1978, H-2 mutations: their genetics and effect on immune functions, Adv Immunol, 26, 55, 10.1016\u002FS0065-2776(08)60229-1\nGraeber, 1990, Microglia: immune network in the CNS, Brain Pathol, 1, 2, 10.1111\u002Fj.1750-3639.1990.tb00630.x\nMcCarron, 1990, Class II major histocompatibility antigen expression in central nervous system: microglia, astrocytes, and endothelial cells, 467\nMato, 1986, Tridimensional observation of fluorescent granular perithelial (FGP) cells in rat cerebral blood vessels, Anat Rec, 215, 413, 10.1002\u002Far.1092150413\nBartlett, 1990, Allograft rejection overcome by immunoselection of neuronal precursor cells, 153\nLampson, 1986, Defining the mechanisms that govern immune acceptance or rejection of neural tissue, 243\nLoveland, 1986, The non-MHC transplantation antigens: neither weak nor minor, Immunol Today, 7, 223, 10.1016\u002F0167-5699(86)90109-X\nFleming, 1981, An immunogenetic analysis of skin antigens in mice, Immunogenetics, 14, 517, 10.1007\u002FBF00350123",{"EN":415},"Immunologic responses in central nervous system transplantation",{"VOID":417},"10.1016\u002F1044-5765(92)90042-z","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F104457659290042Z",[420,435],{"id":421,"sortIndex":19,"researcher":18,"roles":422,"affiliations":423,"properties":432},"ec1414e7-7548-4ea0-80dd-267608389137",[66],[424],{"id":18,"sortIndex":19,"affiliation":425,"properties":18},{"id":426,"createTime":427,"updateTime":427,"relativeEntities":428,"slug":18,"properties":429,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"f37687cf-b367-484b-93cb-3365c52c44b1","2023-12-13T18:46:25.327+00:00",[],{"title":430},{"VI":431},"From the Department of Neurology and the Brain Research Institute, University of Chicago, 5841 South Maryland Ave, Chicago, IL 60637, USA",{"title":433},{"VI":434},"M.K. Nicholas",{"id":436,"sortIndex":64,"researcher":18,"roles":437,"affiliations":438,"properties":444},"92a0f3f6-5f45-408f-b16a-cfc468f5b414",[66],[439],{"id":18,"sortIndex":19,"affiliation":440,"properties":18},{"id":426,"createTime":427,"updateTime":427,"relativeEntities":441,"slug":18,"properties":442,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":443},{"VI":431},{"title":445},{"VI":446},"B.G.W. Arnason",{"url":418,"publisher":448,"properties":462},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":449,"slug":10,"properties":450,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":453,"manageAffiliations":454,"indexDatabases":455,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":451,"title":452},{"VOID":13},{"EN":15},[],[],[456],{"id":24,"indexDatabase":457,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":458,"label":459,"description":460,"key":34,"publicationTags":461,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":463,"pages":465},{"VOID":464},"4",{"VOID":466},"273-283","1992-08-01",1992,{"id":470,"createTime":471,"updateTime":472,"relativeEntities":473,"slug":474,"properties":475,"entityType":57,"verifyStatus":17,"verifyTime":472,"verifyNote":305,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":482,"fullTextUrl":18,"authors":483,"publicationType":92,"publisherRelationship":498,"citationCount":18,"citationInfo":18,"publishDate":517,"publishYear":336,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"598f278d-3ca6-4ebc-b11e-e8df413399ad","2024-01-20T07:44:51.360+00:00","2025-02-19T22:40:11.106+00:00",[],"Amphetamine-conditioned-cue-preference-and-the-neurobiology-of-drug-seeking",{"references":476,"title":478,"doi":480},{"VOID":477},"Kozlowski, 1987, Use and misuse of the concept of craving by alcohol, tobacco and drug researchers, Br J Addict, 82, 31, 10.1111\u002Fj.1360-0443.1987.tb01430.x\nWise, 1988, The neurobiology of craving: implications for the understanding and treatment of addiction, J Abnorm Psychol, 97, 118, 10.1037\u002F0021-843X.97.2.118\nPickens, 1971, Characteristics of stimulant drug reinforcement, 172\nLe Moal, 1991, Mesocorticolimbic dopaminergic network: functional and regulatory roles, Physiol Rev, 716, 155, 10.1152\u002Fphysrev.1991.71.1.155\nCarr, 1989, Conditioned place preference as a measure of drug reward, 264\nWhite, 1993, Acquisition of a spatial conditioned place preference is impaired by amygdala lesions and improved by fornix lesions, Behav Br Res, 55, 269, 10.1016\u002F0166-4328(93)90122-7\nSpyraki, 1982, Dopaminergic substrates of amphetamine-induced place preference conditioning, Brain Res, 253, 185, 10.1016\u002F0006-8993(82)90685-0\nBeach, 1957, Morphine addiction in rats, Can J Psychol, 11, 104, 10.1037\u002Fh0083703\nMucha, 1982, Drug reinforcement studied by the use of place conditioning in rat, Brain Res, 243, 91, 10.1016\u002F0006-8993(82)91123-4\nWhite, 1992, The psychobiology of reinforcers, Annu Rev Psychol, 43, 443, 10.1146\u002Fannurev.ps.43.020192.002303\nGawin, 1986, Abstinence symptomatology and psychiatric diagnosis in cocaine abusers, Arch Gen Psychiat, 43, 107, 10.1001\u002Farchpsyc.1986.01800020013003\nHiroi, 1991, The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas, Brain Res, 552, 141, 10.1016\u002F0006-8993(91)90672-I\nClarke, 1990, 6-Hydroxydopamine lesions of the olfactory tubercle do not alter (+)-amphetamine-conditioned place preference, Behav Brain Res, 36, 185, 10.1016\u002F0166-4328(90)90173-C\nCarr, 1983, Conditioned place preference from intra-accumbens but not intracaudate amphetamine injections, Life Sci, 33, 2551, 10.1016\u002F0024-3205(83)90165-0\nCarr, 1986, Anatomical dissociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study, Psychopharmacol, 89, 340, 10.1007\u002FBF00174372\nHiroi, 1991, The lateral nucleus of the amygdala mediates expression of the amphetamine conditioned place preference, J Neurosci, 11, 2107, 10.1523\u002FJNEUROSCI.11-07-02107.1991\nJones, 1972, Limbic lesions and the problem of stimulus-reinforcement associations, Exp Neurol, 36, 362, 10.1016\u002F0014-4886(72)90030-1\nGaffan, 1992, Amygdala and the memory of reward, 471\nEveritt, 1989, Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement, Neurosci, 30, 63, 10.1016\u002F0306-4522(89)90353-9\nCador, 1989, Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum, Neurosci, 30, 77, 10.1016\u002F0306-4522(89)90354-0\nMcDonald, 1993, A triple dissociation of memory systems: hippocampus, amygdala and dorsal striatum, Behav Neurosci, 107, 3, 10.1037\u002F0735-7044.107.1.3\nNishijo, 1988, Topographic distribution of modality-specific amygdalar neurons in alert monkey, J Neurosci, 8, 3556, 10.1523\u002FJNEUROSCI.08-10-03556.1988\nNishijo, 1988, Single neuron responses in amygdala of alert monkey during complex sensory stimulation with affective significance, J Neurosci, 8, 3570, 10.1523\u002FJNEUROSCI.08-10-03570.1988\nHiroi, 1993, The ventral pallidum area is involved in the acquisition but not expression of the amphetamine conditioned place preference, Neurosci Lett, 156, 9, 10.1016\u002F0304-3940(93)90426-L\nZaborsky, 1992, Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat, Brain Res, 570, 92, 10.1016\u002F0006-8993(92)90568-T\nWoolf, 1986, Cholinergic and non-cholinergic projections from the basal forebrain revealed by combined acetyltransferase and Phaseolus vulgaris leucoagglutinin immunohistochemistry, Neurosci Lett, 66, 281, 10.1016\u002F0304-3940(86)90032-7\nLuiten, 1987, Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin, Brain Res, 413, 229, 10.1016\u002F0006-8993(87)91014-6\nKelley, 1982, The amygdalo-striatal projection in the rat—an anatomical study by anterograde and retrograde tracing methods, Neurosci, 7, 615, 10.1016\u002F0306-4522(82)90067-7\nPhillipson, 1985, The topographic order of inputs to nucleus accumbens in the rat, Neurosci, 16, 275, 10.1016\u002F0306-4522(85)90002-8\nGonzales, 1990, Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L), J Comp Neurol, 297, 182, 10.1002\u002Fcne.902970203\nBechara, 1989, The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine, J Neurosci, 9, 3400, 10.1523\u002FJNEUROSCI.09-10-03400.1989\nMackey, 1985, Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning, Pharmacol Biochem Behav, 22, 101, 10.1016\u002F0091-3057(85)90492-7\nMithani, 1986, The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity, Psychopharmacol, 90, 247, 10.1007\u002FBF00181251\nLeone, 1987, Blockade of D1 receptors by SCH23390 antagonizes morphine—and amphetamine—induced place preference conditioning, Eur J Pharmacol, 135, 251, 10.1016\u002F0014-2999(87)90621-2\nvan der Kooy, 1983, Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions, Brain Res, 259, 111, 10.1016\u002F0006-8993(83)91071-5\nBeninger, 1992, D-1 receptor involvement in reward-related learning, J Psychopharmacol, 6, 34, 10.1177\u002F026988119200600109\nHoffman, 1988, Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning, Pharmacol Biochem Behav, 31, 1, 10.1016\u002F0091-3057(88)90302-4\nWhite, 1991, Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens, Psychopharmacol, 103, 271, 10.1007\u002FBF02244216\nSunahara, 1991, Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, Nature, 350, 614, 10.1038\u002F350614a0\nVan Tol, 1991, Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine, Nature, 350, 610, 10.1038\u002F350610a0\nSchwartz, 1992, The dopamine receptor family: molecular biology and pharmacology, Semin Neurosci, 4, 99, 10.1016\u002F1044-5765(92)90008-P\nHoffman, 1989, The effects of selective dopamine D1 or receptor antagonists on the establishment of agonist-induced place conditioning in rats, Pharmacol Biochem Behav, 33, 273, 10.1016\u002F0091-3057(89)90499-1\nGlowinski, 1970, Storage and release of monoamines in the central nervous system, 91\nGlowinski, 1973, Some characteristics of the functional and main storage compartments in cerebral catecholaminergic neurons, Brain Res, 62, 489, 10.1016\u002F0006-8993(73)90713-0\nStolk, 1970, Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response, Neuropharmacol, 9, 249, 10.1016\u002F0028-3908(70)90074-2\nScheel-Kruger, 1971, Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain, Eur J Pharmacol, 14, 47, 10.1016\u002F0014-2999(71)90121-X\nHiroi, 1991, A pharmacological and neuroanatomical investigation of the conditioned place preference produced by amphetamine\nHiroi, 1990, The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm, Brain Res, 510, 33, 10.1016\u002F0006-8993(90)90724-P\nWise, 1982, Neuroleptics and operant behavior: the anhedonia hypothesis, Behav Brain Sci, 5, 39, 10.1017\u002FS0140525X00010372\nBeninger, 1989, Dissociating the effects of altered dopaminergic function on performance and learning, Brain Res Bull, 23, 365, 10.1016\u002F0361-9230(89)90223-2\nLeDoux, 1991, Overlapping projections to the amygdala and striatum from auditory processing areas of the thalamus and cortex, Neurosci Letts, 134, 139, 10.1016\u002F0304-3940(91)90526-Y\nRusschen, 1982, Amygdalopetal projections in the cat. I. Cortical afferent connections. A study with retrograde and anterograde tracing techniques, J Comp Neurol, 206, 159, 10.1002\u002Fcne.902060206\nDe Olmos, 1985, Amygdala, Vol 1, 223\nZahm, 1992, On the significance of subterritories in the ‘accumbens’ part of the rat ventral striatum, Neurosci, 50, 751, 10.1016\u002F0306-4522(92)90202-D\nSharp, 1987, A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis, Brain Res, 401, 322, 10.1016\u002F0006-8993(87)91416-8\nRobinson, 1990, Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats?, Neuropsychopharmacol, 3, 163\nKiyatkin, 1992, Electrochemical monitoring of extracellular dopamine levels in rat nucleus accumbens during cocaine self-administration, 165\nBlackburn, 1992, Dopamine functions in appetitive and defensive behaviours, Prog Neurobiol, 39, 247, 10.1016\u002F0301-0082(92)90018-A\nWhite, 1989, A functional hypothesis concerning the striatal matrix and patches: mediation of S-R memory and reward, Life Sci, 45, 1943, 10.1016\u002F0024-3205(89)90569-9\nMogenson, 1991, Neuromodulatory functions of the mesolimbic dopamine system: electrophysiological and behavioral studies, 105\nMilner, 1977, Theories of reinforcement, drive and motivation, Vol 7, 181\nWhite, 1987, Operationalizing and measuring the organizing influence of drugs on behavior, 591\nKoob, 1992, Dopamine, addiction and reward, Semin Neurosci, 4, 139, 10.1016\u002F1044-5765(92)90012-Q\nWise, 1989, Brain dopamine and reward, Annu Rev Psychol, 40, 191, 10.1146\u002Fannurev.ps.40.020189.001203\nDi Chiara, 1992, Drug motivation and abuse: a neurobiological perspective, Ann N Y Acad Sci, 654, 207, 10.1111\u002Fj.1749-6632.1992.tb25969.x\nLyon, 1975, The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects, Curr Dev Psychopharmacol, 2, 80\nStewart, 1987, Conditioned drug effects, Vol. 19, 1",{"EN":479},"Amphetamine conditioned cue preference and the neurobiology of drug-seeking",{"VOID":481},"10.1016\u002Fs1044-5765(05)80040-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576505800405",[484,491],{"id":485,"sortIndex":19,"researcher":18,"roles":486,"affiliations":487,"properties":488},"223af387-64d8-491c-82cd-35dbc367faae",[66],[],{"title":489},{"VI":490},"Norman M. White",{"id":492,"sortIndex":64,"researcher":18,"roles":493,"affiliations":494,"properties":495},"93be5055-17b5-46de-b63b-106ef1bb17ff",[66],[],{"title":496},{"VI":497},"Noboru Hiroi",{"url":482,"publisher":499,"properties":513},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":500,"slug":10,"properties":501,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":504,"manageAffiliations":505,"indexDatabases":506,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":502,"title":503},{"VOID":13},{"EN":15},[],[],[507],{"id":24,"indexDatabase":508,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":509,"label":510,"description":511,"key":34,"publicationTags":512,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":514,"pages":515},{"VOID":332},{"VOID":516},"329-336","1993-10-01",{"id":519,"createTime":520,"updateTime":521,"relativeEntities":522,"slug":523,"properties":524,"entityType":57,"verifyStatus":58,"verifyTime":521,"verifyNote":59,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":531,"fullTextUrl":18,"authors":532,"publicationType":92,"publisherRelationship":585,"citationCount":18,"citationInfo":18,"publishDate":403,"publishYear":404,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"5c5d5fe4-7c66-45a0-a91b-b2861ddf41b3","2024-01-01T09:30:56.774+00:00","2025-02-06T22:36:40.047+00:00",[],"Activity-Dependent-Plasticity-in-Adult-Somatic-Sensory-Cortex",{"references":525,"title":527,"doi":529},{"VOID":526},"Artola, 1993, Long term depression of excitatory synaptic transmission and its relationship to long-term potentiation, Trends Neurosci., 16, 480, 10.1016\u002F0166-2236(93)90081-V\nCastro-Alamancos, 1995, Different forms of synaptic plasticity in somatosensory and motor areas of the neocortex, J. Neurosci., 15, 5324, 10.1523\u002FJNEUROSCI.15-07-05324.1995\nBliss, 1973, Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path, J. Physiol. (London), 232, 331, 10.1113\u002Fjphysiol.1973.sp010273\nHubel, 1963, Single-cell responses in striate cortex of kittens deprived of vision in one eye, J. Neurophysiol., 26, 1003, 10.1152\u002Fjn.1963.26.6.1003\nDiamond, 1993, Experience-dependent plasticity in adult rat barrel, Proc. Natl. Acad. Sci. USA, 90, 2082, 10.1073\u002Fpnas.90.5.2082\nRecanzone, 1992, Topographic reorganization of the hand representation in cortical area 3b of owl monkeys trained in a frequency-discrimination task, J. Neurophysiol., 67, 1031, 10.1152\u002Fjn.1992.67.5.1031\nRamachandran, 1992, Perceptual correlates of massive cortical reorganization, Neuroreport, 3, 583, 10.1097\u002F00001756-199207000-00009\nFlor, 1995, Phantom-limb pain as a perceptual correlate of cortical organization following arm amputation, Nature, 375, 482, 10.1038\u002F375482a0\nKnecht, 1995, Cortical reorganization in human amputees and mislocalization of painful stimuli to the phantom limb, Neurosci. Lett., 201, 262, 10.1016\u002F0304-3940(95)12186-2\nMogilner, 1993, Somatosensory cortical plasticity in adult humans revealed by magnetoencephalography, Proc. Natl. Acad. Sci. USA, 90, 3593, 10.1073\u002Fpnas.90.8.3593\nAllard, 1991, Reorganization of somatosensory area 3b representation in adult owl monkeys after digital syndactyly, J. Neurophysiol., 66, 1048, 10.1152\u002Fjn.1991.66.3.1048\nElbert, 1995, Increased cortical representation of the fingers of the left hand in string players, Science, 270, 305, 10.1126\u002Fscience.270.5234.305\nPascual-Leone, 1993, Plasticity of the sensorimotor cortex representation of the reading finger in Braille readers, Brain, 116, 39, 10.1093\u002Fbrain\u002F116.1.39\nSadato, 1996, Activation of the primary viual cortex by Braille reading in blind subjects, Nature, 11, 479\nMerzenich, 1983, Topographic reorganization of somatosensory cortical areas 3b and 1 in adult monkeys following restricted deafferentation, Neuroscience, 8, 33, 10.1016\u002F0306-4522(83)90024-6\nMerzenich, 1984, Somatosensory cortical map changes following digit amputation in adult monkeys, J. Comp. Neurol., 224, 591, 10.1002\u002Fcne.902240408\nRasmusson, 1982, Reorganization of raccoon somatosensory cortex following removal of the fifth digit, J. Comp. Neurol., 205, 316, 10.1002\u002Fcne.902050402\nWall, 1984, Cutaneous responsiveness in primary somatosensory (SI) hindpaw cortex before and after partial hindpaw deafferentation in adult rats, J. Neurosci., 4, 1499, 10.1523\u002FJNEUROSCI.04-06-01499.1984\nCalford, 1988, Immediate and chronic changes in responses of somatosensory cortex in adult flying-fox after digit amputation, Nature, 332, 446, 10.1038\u002F332446a0\nWall, 1983, Recovery of normal topography in the somatosensory cortex of monkeys after nerve crush and regeneration, Science, 221, 771, 10.1126\u002Fscience.6879175\nRecanzone, 1992, Progressive improvement in discrimination abilities in adult owl monkeys performing a tactile frequency discrimination task, J. Neurophysiol., 67, 1015, 10.1152\u002Fjn.1992.67.5.1015\nRecanzone, 1992, Frequency discrimination training engaging a restricted skin surface results in an emergence of a cutaneous response zone in cortical area 3a, J. Neurophysiol., 67, 1057, 10.1152\u002Fjn.1992.67.5.1057\nRecanzone, 1992, Changes in the distributed temporal response properties of SI cortical neurons reflect improvements in performance on a temporally based tactile discrimination task, J. Neurophysiol., 67, 1071, 10.1152\u002Fjn.1992.67.5.1071\nByl, 1996, A primate genesis model of focal dystonia and repetitive strain injury. I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys, Neurology, 47, 508, 10.1212\u002FWNL.47.2.508\nDelacour, 1987, “Learned” changes in the responses of the rat barrel field neurons, Neuroscience, 23, 63, 10.1016\u002F0306-4522(87)90271-5\nArmstrong-James, 1994, An innocuous bias in whisker use in adult rats modifies receptive fields of barrel cortex neurons, J. Neurosci., 14, 6978, 10.1523\u002FJNEUROSCI.14-11-06978.1994\nWelker, 1989, Plasticity in the barrel cortex of the adult mouse: Effects of peripheral deprivation on GAD-immunoreactivity, Brain Res., 74, 441, 10.1007\u002FBF00247346\nIto, 1985, Processing of vibrissa sensory information within the rat neocortex, J. Neurophysiol., 54, 479, 10.1152\u002Fjn.1985.54.3.479\nSimons, 1985, Temporal and spatial integration in the rat SI Vibrissa Cortex, J. Neurophysiol., 54, 615, 10.1152\u002Fjn.1985.54.3.615\nArmstrong-James, 1987, Spatiotemporal convergence and divergence in the rat S1 “barrel” cortex, J. Comp. Neurol., 263, 265, 10.1002\u002Fcne.902630209\nArmstrong-James, 1991, Thalamo-cortical processing of vibrissal information in the rat. I. intracortical origins of surround but not centre receptive fields of layer IV neurones in the rat SI barrel field cortex, J. Comp. Neurol., 303, 193, 10.1002\u002Fcne.903030203\nArmstrong-James, 1991, Thalamo-cortical processing of vibrissal information in the rat. II. Spatiotemporal convergence in the thalamic ventroposterior medial nucleus (VPm) and its relevance to generation of receptive fields of S1 cortical “barrel” neurones, J. Comp. Neurol., 303, 211, 10.1002\u002Fcne.903030204\nDiamond, 1994, Laminar comparison of somatosensory cortical plasticity, Science, 265, 1885, 10.1126\u002Fscience.8091215\nHuang, 1995, The influence of early whisker sensory deprivation on cortical plasticity in the adult rat, Neurosci. Abstr., 54, 123\nSiegelbaum, 1991, Learning-related synaptic plasticity: LTP and LTD, Curr. Opin. Neurobiol., 1, 113, 10.1016\u002F0959-4388(91)90018-3\nBear, 1987, A physiological basis for a theory of synapse modification, Science, 237, 42, 10.1126\u002Fscience.3037696\nBear, 1994, Synaptic plasticity: LTP and LTD, Curr. Opin. Neurobiol., 4, 389, 10.1016\u002F0959-4388(94)90101-5\nConnor, 1994, Calcium signaling in dendritic spines of hippocampal neurons, J. Neurobiol., 25, 234, 10.1002\u002Fneu.480250304\nGuthrie, 1991, Independent regulation of calcium revealed by imaging dendritic spines, Nature, 354, 76, 10.1038\u002F354076a0\nByrne, 1996, Presynaptic facilitation revisited: State and time dependence, J. Neurosci., 16, 425, 10.1523\u002FJNEUROSCI.16-02-00425.1996\nColonnier, 1968, Synaptic patterns on different cell types in the different laminae of the cat visual cortex. An electron microscope study, Brain Res., 9, 268, 10.1016\u002F0006-8993(68)90234-5\nValverde, 1967, Apical dendritic spines of the visual cortex and light deprivation in the mouse, Exp. Brain Res., 3, 337, 10.1007\u002FBF00237559\nRyugo, 1975, Changes in pyramidal cell density consequent to vibrissae removal in the newborn rat, Brain Res., 96, 82, 10.1016\u002F0006-8993(75)90575-2\nFreire, 1978, Effects of dark rearing on dendritic spines in layer IV of the mouse visual cortex: A quantitative electron microscopical study, J. Anat., 126, 193\nMarin-Padilla, 1972, Structural abnormalities of the cerebral cortex in human chromosomal aberrations: A Golgi study, Brain Res., 44, 625, 10.1016\u002F0006-8993(72)90324-1\nPurpura, 1974, Dendritic spine ‘dysgenesis’ and mental retardation, Science, 186, 1126, 10.1126\u002Fscience.186.4169.1126\nDiamond, 1986\nGreenough, 1986, What's special about development? Thoughts on the bases of experience-sensitive synaptic plasticity\nNakanishi, 1992, Molecular diversity of glutamate receptors and implications for brain function, Science, 258, 597, 10.1126\u002Fscience.1329206\nJones, 1991, Both NMDA and non-NMDA subtypes of glutamate receptors are concentrated at synapses on cerebral cortical neurons in culture, Neuron, 7, 593, 10.1016\u002F0896-6273(91)90372-7\nJonas, 1994, Mechanisms shaping glutamate-mediated excitatory postsynaptic currents in the CNS, Curr. Biol., 4, 366\nSommer, 1992, Glutamate receptor channels: novel properties and new clones, Trends Pharmacol. Sci., 13, 291, 10.1016\u002F0165-6147(92)90088-N\nRema, 1996, Postnatal changes in NMDAR1 subunit expression in the rat trigeminal pathway to barrel field cortex, J. Comp. Neurol., 368, 165, 10.1002\u002F(SICI)1096-9861(19960429)368:2\u003C165::AID-CNE1>3.0.CO;2-1\nArmstrong-James, 1993, Different roles for NMDA and non-NMDA receptors in fast and slow sensory transmission by the rat SI barrel cortex neuronesin vivo, J. Physiol., 467, 91P\nArmstrong-James, 1996, An innocuous bias in whisker use in adult rats alters relative NMDA and AMPA receptor sensory transmission in barrel field cortex, Soc. Neurosci. Abstr.\nRema, 1997, Soc. Neurosci. Abstr.\nGarraghty, 1996, NMDA receptors and plasticity in adult primate somatosensory cortex, J. Comp. Neurol., 367, 319, 10.1002\u002F(SICI)1096-9861(19960401)367:2\u003C319::AID-CNE12>3.0.CO;2-L\nAkhtar, 1991, Activity-dependent regulation of glutamic acid decarboxylase in the rat barrel cortex: Effects of neonatal versus adult sensory deprivation, J. Comp. Neurol., 307, 200, 10.1002\u002Fcne.903070204\nWelker, 1971, Microelectrode delineation of fine grain somatotopic organization of SmI cerebral neocortex in albino rat, Brain Res., 26, 259\nWelker, 1989, Plasticity in the barrel cortex of the adult mouse: Transient increase of GAD-immunoreactivity following sensory stimulation, Exp. Brain Res., 78, 659, 10.1007\u002FBF00230256\nLin, 1985, Glutamic acid decarboxylase immunoreactivity in layer IV of barrel cortex of rat and mouse, J. Neurosci., 5, 1934, 10.1523\u002FJNEUROSCI.05-07-01934.1985\nEbner, 1994, Localization of NMDAR1 subunit in rat layer IV barrel cells, Soc. Neurosci. Abstr., 20, 1384\nSachdev, 1995, Effects of acetylcholine depletion in the rat barrel cortex, Soc. Neurosci. Abstr., 21, 123\nMetherate, 1988, Transient and prolonged effects of acetylcholine on responsiveness of cat somatosensory cortical neurons, J. Neurophysiol., 59, 1253, 10.1152\u002Fjn.1988.59.4.1253\nJacobs, 1994, Cholinergic basal forebrain transplants restore diminished metabolic activity in the somatosensory cortex of rats with acetylcholine depletion, J. Neurosci., 14, 697, 10.1523\u002FJNEUROSCI.14-02-00697.1994\nLu, 1996, Effects of norepinephrine (NE) depletion in the rat barrel cortex, Soc. Neurosci. Abstr., 22, 1357\nBoyeson, 1990, Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury, Pharmacol. Biochem. Behav., 35, 497, 10.1016\u002F0091-3057(90)90279-Q\nAuerbach, 1992, Acetylcholine enhances NMDA evoked calcium rise in hippocampal neurons, Brain Res., 587, 83, 10.1016\u002F0006-8993(92)91430-M\nRoche, 1994, Glutamate receptor phosporylation and synaptic plasticity, Curr. Opin. Neurobiol., 4, 383, 10.1016\u002F0959-4388(94)90100-7\nSoderling, 1993, J. Neurobiol., 25, 304, 10.1002\u002Fneu.480250310\nEhlers, 1995, Regulated subcellular distribution of the NR1 subunit of the NMDA receptor, Science, 269, 1734, 10.1126\u002Fscience.7569904\nRosen, 1992, Brief visual experience induces immediate early gene expression in the cat visual cortex, Proc. Natl. Acad. Sci. USA, 89, 5437, 10.1073\u002Fpnas.89.12.5437\nWorley, 1991, Constitutive expression of Zif268 in neocortex is regulated by synaptic activity, Proc. Natl. Acad. Sci. USA, 88, 5106, 10.1073\u002Fpnas.88.12.5106\nChaudhuri, 1993, Activity-dependent expression of the transcription factor Zif268 reveals ocular dominance columns in mondey visual cortex, Brain Res., 605, 349, 10.1016\u002F0006-8993(93)91765-K",{"EN":528},"Activity-Dependent Plasticity in Adult Somatic Sensory Cortex",{"VOID":530},"10.1006\u002Fsmns.1997.0105","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576597901056",[533,548,560,573],{"id":534,"sortIndex":64,"researcher":18,"roles":535,"affiliations":536,"properties":545},"616357f5-1227-4fb4-98b6-48922407614f",[66],[537],{"id":18,"sortIndex":19,"affiliation":538,"properties":18},{"id":539,"createTime":540,"updateTime":540,"relativeEntities":541,"slug":18,"properties":542,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"14adcf51-dfbe-4039-9ab8-2706ae4dacc0","2024-01-01T09:30:56.795+00:00",[],{"title":543},{"VI":544},"Institute for Developmental Neuroscience, John F. Kennedy Center for Studies on Human Development, Vanderbilt University, Nashville, Tennessee, 37203",{"title":546},{"VI":547},"V. Rema",{"id":549,"sortIndex":184,"researcher":18,"roles":550,"affiliations":551,"properties":557},"729be73b-df6b-4602-959b-bcbd20db43e5",[66],[552],{"id":18,"sortIndex":19,"affiliation":553,"properties":18},{"id":539,"createTime":540,"updateTime":540,"relativeEntities":554,"slug":18,"properties":555,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":556},{"VI":544},{"title":558},{"VI":559},"R. Sachdev",{"id":561,"sortIndex":562,"researcher":18,"roles":563,"affiliations":564,"properties":570},"af8a499a-5943-4410-a36a-e9106dcf9e27",3,[66],[565],{"id":18,"sortIndex":19,"affiliation":566,"properties":18},{"id":539,"createTime":540,"updateTime":540,"relativeEntities":567,"slug":18,"properties":568,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":569},{"VI":544},{"title":571},{"VI":572},"F.J. Symons",{"id":574,"sortIndex":19,"researcher":18,"roles":575,"affiliations":576,"properties":582},"acce1604-1f17-4ec0-986e-8790fe52d848",[66],[577],{"id":18,"sortIndex":19,"affiliation":578,"properties":18},{"id":539,"createTime":540,"updateTime":540,"relativeEntities":579,"slug":18,"properties":580,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":581},{"VI":544},{"title":583},{"VI":584},"F.F. Ebner",{"url":531,"publisher":586,"properties":600},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":587,"slug":10,"properties":588,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":591,"manageAffiliations":592,"indexDatabases":593,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":589,"title":590},{"VOID":13},{"EN":15},[],[],[594],{"id":24,"indexDatabase":595,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":596,"label":597,"description":598,"key":34,"publicationTags":599,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":601,"pages":602},{"VOID":400},{"VOID":603},"47-58",{"id":605,"createTime":606,"updateTime":606,"relativeEntities":607,"slug":18,"properties":608,"entityType":57,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":613,"fullTextUrl":18,"authors":614,"publicationType":92,"publisherRelationship":654,"citationCount":18,"citationInfo":18,"publishDate":673,"publishYear":291,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":115},"8076cb37-cfa6-4838-ba0e-8cc357d6ce61","2024-01-19T22:35:22.858+00:00",[],{"title":609,"doi":611},{"EN":610},"Molecular biology and physiology of glutamate transporters",{"VOID":612},"10.1006\u002Fsmns.1994.1015","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1044576584710153",[615,630,642],{"id":616,"sortIndex":184,"researcher":18,"roles":617,"affiliations":618,"properties":627},"51e20b67-46a2-469d-ba69-40bef00dcfd5",[66],[619],{"id":18,"sortIndex":19,"affiliation":620,"properties":18},{"id":621,"createTime":622,"updateTime":622,"relativeEntities":623,"slug":18,"properties":624,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a0d2140a-9c0c-4587-9db3-72c419978062","2024-01-19T22:35:22.890+00:00",[],{"title":625},{"VI":626},"From the Department of Physiology, University College London, Gower Street, London WC1E 6BT, UK",{"title":628},{"VI":629},"David Attwell",{"id":631,"sortIndex":64,"researcher":18,"roles":632,"affiliations":633,"properties":639},"6eac5230-c184-4d43-ad22-1bc83bc881af",[66],[634],{"id":18,"sortIndex":19,"affiliation":635,"properties":18},{"id":621,"createTime":622,"updateTime":622,"relativeEntities":636,"slug":18,"properties":637,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":638},{"VI":626},{"title":640},{"VI":641},"Alessandra Amato",{"id":643,"sortIndex":19,"researcher":18,"roles":644,"affiliations":645,"properties":651},"f3b0c29c-3627-4cec-b364-3c1550eb315a",[66],[646],{"id":18,"sortIndex":19,"affiliation":647,"properties":18},{"id":621,"createTime":622,"updateTime":622,"relativeEntities":648,"slug":18,"properties":649,"entityType":76,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":650},{"VI":626},{"title":652},{"VI":653},"Muriel Bouvier",{"url":613,"publisher":655,"properties":669},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":656,"slug":10,"properties":657,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":660,"manageAffiliations":661,"indexDatabases":662,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":658,"title":659},{"VOID":13},{"EN":15},[],[],[663],{"id":24,"indexDatabase":664,"url":37,"indexYears":38,"academicFieldIds":18,"indexDatabaseRanking":39},{"id":26,"createTime":27,"updateTime":28,"relativeEntities":665,"label":666,"description":667,"key":34,"publicationTags":668,"standard":18},[],{"EN":31,"VI":31},{"EN":31,"VI":33},[36],{"volume":670,"pages":671},{"VOID":287},{"VOID":672},"117-125","1994-04-01"]